<div id="page0" style="width:595.3pt;height:793.7pt">
<img style="position:absolute;transform:matrix(1.3333334,0,0,1.3333334,661.3334,97.333339)" src="data:image/png;base64,
iVBORw0KGgoAAAANSUhEUgAAADgAAAA4CAYAAACohjseAAAACXBIWXMAAA7EAAAO
xAGVKw4bAAABC0lEQVR4nO3P/W7BABiF8XP/l4VZ0ZTQTAjDfDUdhqjRVc/cxLJ4
4iS/9+/3keHTfz/w13sGPvqegY++Z+CjT2VZmkzl7WYyFbfCZCqKH5Mpz3OTKb9e
TabL5dtkOp8zkynLMpPpdDqZTMfjwWQ6HPcm037/ZTLtdluTabvdmEybzafJlKap
yZQkicnugWuTab1emUzL5cJkWizmJtN8/mEyzWYzk2k6nZpM75OJyTQej02m0Whk
Mn7gcDg0mQaDgcnU7/dNprf7IVMcxyZT3OuZTN1u12TqdDomU7sdmUxRFJlMYRia
TGGrZTK1mk2TqdEITKYgCEym13rdZHqp1UymarVqMlUqFZP9AgrcFNScIWpWAAAA
AElFTkSuQmCC">
<p style="top:96.5pt;left:51.0pt;line-height:16.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:16.0pt;color:#131313">Mesenchymal Stem Cell Therapy</span></p>
<p style="top:114.4pt;left:51.0pt;line-height:16.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:16.0pt;color:#131313">for Osteoradionecrosis of the Mandible: a Systematic Review</span></p>
<p style="top:132.4pt;left:51.0pt;line-height:16.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:16.0pt;color:#131313">of Preclinical and Human Studies</span></p>
<p style="top:166.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313">Anders Kierkegaard Gundestrup</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">1</span></sup></p>
<p style="top:168.4pt;left:204.4pt;line-height:8.0pt"><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313">&amp;</span><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313"> Charlotte Duch Lynggaard</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">1</span></sup><sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313"> </span></sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313">&amp;</span><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313"> Lone Forner</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">2</span></sup><sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313"> </span></sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313">&amp;</span><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313"> Terhi J. Heino</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">3</span></sup><sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313"> </span></sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313">&amp;</span></p>
<p style="top:179.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313">Kathrine Kronberg Jakobsen</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">1</span></sup><sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313"> </span></sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313">&amp;</span><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313"> Anne Fischer-Nielsen</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">4</span></sup><sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313"> </span></sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313">&amp;</span><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313"> Christian Gr&#xf8;nh&#xf8;j</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">1</span></sup><sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313"> </span></sup><span style="font-family:NpwpqtLphjjgAdvP0005,serif;font-size:8.0pt;color:#131313">&amp;</span><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:10.0pt;color:#131313"> Christian von Buchwald</span><sup><span style="font-family:HckgnsXkvkwcAdvTT99c4c96,serif;font-size:7.0pt;color:#131313">1</span></sup></p>
<p style="top:218.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:PpsgbkXrrlrxAdvPi3,serif;font-size:8.5pt;color:#131313">#</span><span style="font-family:WrdcxmDnpvvwAdvTTc488b0e,serif;font-size:8.5pt;color:#131313"> Springer Science+Business Media, LLC, part of Springer Nature 2020</span></p>
<p style="top:242.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:GnfgftRwwvyhAdvTTaf7f9f4,serif;font-size:10.0pt;color:#131313">Abstract</span></p>
<p style="top:254.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:10.0pt;color:#131313">Background</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> Osteoradionecrosis (ORN) of the mandible is a severe complication of radiotherapy for head and neck cancer and is</span></p>
<p style="top:266.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">arduously difficult to manage. Current treatment options carry risks with some patients remaining incurable. Mesenchymal stromal/</span></p>
<p style="top:279.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">stem cell (MSC) therapy has shown promising results supporting osteogenesis and regeneration of radiotherapy-damaged tissues.</span></p>
<p style="top:291.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The aim of this study was to systematically review the literature on the safety and efficacy of MSCs in treating ORN.</span></p>
<p style="top:303.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:10.0pt;color:#131313">Methods</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> A systematic search was performed on MEDLINE, Embase, Cochranes Library online databases, and</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> clinicaltrials.gov</span></p>
<p style="top:316.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">to identify preclinical and clinical studies examining the effect of MSCs on osseous healing of ORN. The preclinical studies were</span></p>
<p style="top:328.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">assessed according to the SYRCLEs guidelines and risk of bias tool.</span></p>
<p style="top:340.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:10.0pt;color:#131313">Results</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> Six studies (</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 142) from 5 countries were eligible for analysis. Of these four were preclinical studies and two clinical</span></p>
<p style="top:353.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">case studies. Preclinical studies found MSC treatment to be safe, demonstrating bone restorative effects and improved soft tissue</span></p>
<p style="top:365.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">regeneration. In the clinical cases, healing of bone and soft tissue was reported with no serious adverse events.</span></p>
<p style="top:377.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:10.0pt;color:#131313">Conclusion</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> The evidence from the included studies suggests that MSCs may have beneficial regenerative effects on the healing</span></p>
<p style="top:390.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">of ORN. None of the studies reported adverse events with the use of MSCs. More carefully controlled studies with well-identified</span></p>
<p style="top:402.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cells are however needed to demonstrate the efficacy of MSCs in a clinical setting.</span></p>
<p style="top:439.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:10.0pt;color:#131313">Keywords</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> Osteoradionecrosis </span><sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. </span></sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Mesenchymal stem cells </span><sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. </span></sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Cell therapy </span><sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. </span></sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ORN </span><sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. </span></sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Systematic review</span></p>
<p style="top:477.5pt;left:51.0pt;line-height:12.0pt"><span style="font-family:GnfgftRwwvyhAdvTTaf7f9f4,serif;font-size:12.0pt;color:#131313">Introduction</span></p>
<p style="top:504.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Osteoradionecrosis of the mandible (ORN) is a complication</span></p>
<p style="top:516.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">of high-dose radiotherapy of the head and neck. The currently</span></p>
<p style="top:528.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">accepted definition of the condition is bone devitalization sec-</span></p>
<p style="top:541.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ondary to radiotherapy, where bone becomes exposed through</span></p>
<p style="top:479.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the overlying skin or mucosa without healing for three months</span></p>
<p style="top:491.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">in the absence of recurrent tumor [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 2</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. ORN often occurs as a</span></p>
<p style="top:504.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">consequence of local trauma but may also arise spontaneous-</span></p>
<p style="top:516.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ly, and ranges from small asymptomatic bone exposures to</span></p>
<p style="top:528.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">severe necrosis with pathologic fractures necessitating surgi-</span></p>
<p style="top:541.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cal intervention and reconstruction [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">3</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Recently published</span></p>
<p style="top:553.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">data show that ORN affects approximately 5% of patients</span></p>
<p style="top:566.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">who undergo radiotherapy for head and neck cancer [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">4</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 5</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:578.7pt;left:317.5pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The pathophysiological aetiology of radiation-induced</span></p>
<p style="top:591.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">damage of bone tissue is complex and not fully understood.</span></p>
<p style="top:603.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">In 1983, Marx et al. [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">6</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] presented the pathophysiology of</span></p>
<p style="top:616.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ORN as a hypo-triad; hypoxia, hypocellularity, and</span></p>
<p style="top:628.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">hypovascularity. Consequently, aseptic bone necrosis will de-</span></p>
<p style="top:641.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">velop due to impaired regenerative capacity of the bone and</span></p>
<p style="top:653.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">soft tissue secondary to the radiation-injury and local trauma</span></p>
<p style="top:665.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">[</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">7</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Another theory is that the initial event in developing ORN</span></p>
<p style="top:678.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">is the early radiational damage to osteoclasts, leading to de-</span></p>
<p style="top:690.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">creased osteoclast-related bone turnover, preceding vascular</span></p>
<p style="top:703.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">changes and, ultimately, bone necrosis [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">8</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:579.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:NspxdvWmslbgAdvTT4ff6545,serif;font-size:8.5pt;color:#131313">*</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> Christian von Buchwald</span></p>
<p style="top:589.5pt;left:66.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Christian.von.Buchwald@regionh.dh</span></p>
<p style="top:610.2pt;left:51.0pt;line-height:6.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:6.0pt;color:#131313">1</span></p>
<p style="top:612.0pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Department of Otorhinolaryngology, Head and Neck Surgery and</span></p>
<p style="top:621.9pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Audiology, Rigshospitalet, University of Copenhagen,</span></p>
<p style="top:631.9pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Copenhagen, Denmark</span></p>
<p style="top:645.0pt;left:51.0pt;line-height:6.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:6.0pt;color:#131313">2</span></p>
<p style="top:646.8pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Department of Oral and Maxillofacial Surgery, Rigshospitalet,</span></p>
<p style="top:656.8pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">University of Copenhagen, Copenhagen, Denmark</span></p>
<p style="top:670.0pt;left:51.0pt;line-height:6.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:6.0pt;color:#131313">3</span></p>
<p style="top:671.7pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Institute of Biomedicine, Faculty of Medicine, University of Turku,</span></p>
<p style="top:681.7pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Turku, Finland</span></p>
<p style="top:694.9pt;left:51.0pt;line-height:6.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:6.0pt;color:#131313">4</span></p>
<p style="top:696.6pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Department of Immunology, Cell Therapy Facility, Rigshospitalet,</span></p>
<p style="top:706.6pt;left:65.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">University of Copenhagen, Copenhagen, Denmark</span></p>
<p style="top:44.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:WrdcxmDnpvvwAdvTTc488b0e,serif;font-size:8.5pt">https://doi.org/10.1007/s12015-020-10034-5</span></p>
<p style="top:208.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Published online: 1 September 2020</span></p>
<p style="top:33.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Reviews and Reports (2020) 16:1208&#x2013;1221</span></p>


<p style="top:58.4pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Treatment of mild cases of ORN of the mandible consists</span></p>
<p style="top:70.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">of conservative prevention seeking to avoid further progres-</span></p>
<p style="top:83.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">sion of the disease by good oral hygiene and avoiding predis-</span></p>
<p style="top:95.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">posing factors such as tooth extraction, alcohol, tobacco, and</span></p>
<p style="top:108.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">poor nutritional status [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 4</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 9</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 10</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Hyperbaric oxygen treat-</span></p>
<p style="top:120.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ment (HBO) has proven to hinder further development of</span></p>
<p style="top:133.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">moderate ORN [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">6</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 11</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 12</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Severe cases are treated with sur-</span></p>
<p style="top:145.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">gical resection and free flap transplant in combination with</span></p>
<p style="top:158.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">HBO [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">13</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. However, ORN is notoriously difficult to manage</span></p>
<p style="top:170.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and a considerable percentage of patients remain incurable or</span></p>
<p style="top:182.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">experience recurrent ORN even after successful recovery.</span></p>
<p style="top:195.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Several studies have recently suggested that treatment with</span></p>
<p style="top:207.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">mesenchymal stromal/stem cells (MSCs) might be a viable</span></p>
<p style="top:220.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">treatment option for ORN of the mandible [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:232.7pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs are multipotent adult cells first discovered in the</span></p>
<p style="top:245.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">bone marrow (BM) to support haematopoiesis [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">18</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Since</span></p>
<p style="top:257.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">then, MSCs have been isolated from virtually all connective</span></p>
<p style="top:270.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tissues where they have been shown to support tissue regen-</span></p>
<p style="top:282.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">eration, as well as respond to injuries and inflammation [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">19</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:294.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs are defined by their ability to adhere to plastic in cell</span></p>
<p style="top:307.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cultures, positive expression of specific surface markers</span></p>
<p style="top:319.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(CD90, CD73, CD105) combined with the absence of others</span></p>
<p style="top:332.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(e.g. CD45 and CD14), and the tri-lineage differentiation ca-</span></p>
<p style="top:344.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">pacity into osteoblasts, adipocytes, and chondroblasts</span></p>
<p style="top:357.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">[</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">20</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">22</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. An important mechanism of action is believed to</span></p>
<p style="top:369.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">be the secretion of bioactive molecules promoting angiogen-</span></p>
<p style="top:382.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">esis, anti-apoptosis, immune modulation, antifibrosis, and</span></p>
<p style="top:394.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">support of local stem cells [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">21</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 23</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">26</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> These properties make</span></p>
<p style="top:407.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs promising candidates for clinical cell therapy [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">19</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] and a</span></p>
<p style="top:419.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">treatment option worth considering in radiation-induced dis-</span></p>
<p style="top:431.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">eases, including ORN [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 24</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 27</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">32</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:444.4pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The above mentioned effects of MSCs could promote regen-</span></p>
<p style="top:456.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">eration and soft tissue healing also in ORN, when taking into</span></p>
<p style="top:469.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">consideration the pathophysiology of the hypo-triad, as pro-</span></p>
<p style="top:481.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">posed by Marx et al. [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">6</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. MSCs also have the capacity to di-</span></p>
<p style="top:494.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">rectly differentiate into bone-forming osteoblasts [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">33</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 34</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. This</span></p>
<p style="top:506.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">osteogenic differentiation ability may contribute to the bone</span></p>
<p style="top:519.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tissue regeneration [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">21</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] together with the proposed theory of</span></p>
<p style="top:531.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">decreased osteoclast-related bone turnover, both of which are</span></p>
<p style="top:544.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">needed for restoring the lost bone structure and turnover.</span></p>
<p style="top:556.5pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">There is an unmet need for new treatments for mandibular</span></p>
<p style="top:568.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ORN with no systematic reviews providing evidence of the</span></p>
<p style="top:581.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">potential of MSCs. The objective of this review was thus to</span></p>
<p style="top:593.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">assess the safety and efficacy of MSCs on mandibular ORN in</span></p>
<p style="top:606.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">preclinical and human studies and thereby evaluate the poten-</span></p>
<p style="top:618.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tial use of MSCs for ORN in future human trials.</span></p>
<p style="top:654.5pt;left:51.0pt;line-height:12.0pt"><span style="font-family:GnfgftRwwvyhAdvTTaf7f9f4,serif;font-size:12.0pt;color:#131313">Methods</span></p>
<p style="top:681.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">This systematic review adheres to the Preferred Reporting</span></p>
<p style="top:693.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Items for Systematic Reviews and Meta-Analyses</span></p>
<p style="top:705.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(PRISMA) statement [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">35</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. The approach, method, and search</span></p>
<p style="top:58.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">string were agreed within the author group. We considered</span></p>
<p style="top:70.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">animal studies, which examined the effects of MSCs for</span></p>
<p style="top:83.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ORN of the mandible versus a control group, and all eligible</span></p>
<p style="top:95.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">human studies regardless of their publication date. Studies</span></p>
<p style="top:108.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">examining the effects of MSCs in combination with other</span></p>
<p style="top:120.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">treatment regimens, studies without original data as well as</span></p>
<p style="top:133.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">preclinical studies without a control group were excluded. The</span></p>
<p style="top:145.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">primary outcome was safety. The secondary outcome was</span></p>
<p style="top:158.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">signs of osseous healing.</span></p>
<p style="top:182.1pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Search Strategy</span></p>
<p style="top:207.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">In July 2019, we systematically searched for English and</span></p>
<p style="top:220.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Scandinavian language articles in MEDLINE, Embase,</span></p>
<p style="top:232.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Cochrane Library online databases, and ongoing clinical trials</span></p>
<p style="top:245.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">were searched for in</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> clinicaltrials.gov</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. MEDLINE and</span></p>
<p style="top:257.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">EMBASE were searched using the following keywords</span></p>
<p style="top:270.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(including MeSH terms): Osteoradionecrosis, mesenchymal</span></p>
<p style="top:282.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">stem cells, MSC, stem cells, bone marrow mesenchymal</span></p>
<p style="top:294.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">stem cells, bone marrow aspirate concentrate, adipose stem</span></p>
<p style="top:307.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cells, adipose derived stem cells, stem cell transplantation,</span></p>
<p style="top:319.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">mesenchymal progenitor cells, and Wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">s jelly cells.</span></p>
<p style="top:332.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The full search terms including all specific search terms, and</span></p>
<p style="top:344.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the details of the search are described in</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> Appendix</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. Besides</span></p>
<p style="top:357.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the search of databases reference lists were evaluated for</span></p>
<p style="top:369.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">further relevant articles.</span></p>
<p style="top:393.8pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Data Extraction</span></p>
<p style="top:419.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Two authors (AG and LF) independently identified studies</span></p>
<p style="top:432.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">against the inclusion criteria to determine the eligibility. The</span></p>
<p style="top:444.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">following information was recorded from included studies</span></p>
<p style="top:456.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">using the Covidence systematic review software (Covidence</span></p>
<p style="top:469.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">2020): year of publication, author, study design, the species</span></p>
<p style="top:481.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and number of animals used in the study, the graft donor</span></p>
<p style="top:494.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">species, patient demographics, the origin of the MSCs, the</span></p>
<p style="top:506.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">treatment model/intervention, number of cells, statistical tests</span></p>
<p style="top:519.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">used, the method used for inducing osteoradionecrosis, infor-</span></p>
<p style="top:531.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">mation on blinding, allocation, control groups, outcomes, ad-</span></p>
<p style="top:544.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">verse events, and follow-up time.</span></p>
<p style="top:568.1pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Data Analysis</span></p>
<p style="top:593.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The preclinical studies were evaluated according to the</span></p>
<p style="top:606.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">SYRCLEs guidelines and risk of bias tool. The publication</span></p>
<p style="top:618.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">bias was evaluated using funnel plot and small-study effect</span></p>
<p style="top:631.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">using Egger regression.</span></p>
<p style="top:667.0pt;left:306.1pt;line-height:12.0pt"><span style="font-family:GnfgftRwwvyhAdvTTaf7f9f4,serif;font-size:12.0pt;color:#131313">Results</span></p>
<p style="top:693.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Six studies published in 2010</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">2017 met the inclusion criteria</span></p>
<p style="top:705.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(Fig.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">). Four animal studies (</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 139, intervention groups</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313"> n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> =</span></p>
<p style="top:33.5pt;left:528.3pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1209</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:430.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">49) (Table</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">) and two human case studies (</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 3) (Table</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 2</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">)</span></p>
<p style="top:442.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">were identified.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> Clinicaltrials.gov</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> showed one randomised</span></p>
<p style="top:455.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">controlled trial including human ORN cases, which might</span></p>
<p style="top:467.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">have met the inclusion criteria, but the authors of that trial</span></p>
<p style="top:480.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">did not respond to our requests, nor have any results been</span></p>
<p style="top:492.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">published so far. Cochrane Library did not present any</span></p>
<p style="top:505.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">studies meeting our inclusion criteria.</span></p>
<p style="top:517.6pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Owing to the limited number and the heterogeneity of the</span></p>
<p style="top:530.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">studies, it was not possible to perform meta-analysis or evaluate</span></p>
<p style="top:542.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">small-study effects using a funnel plot or Egger regression.</span></p>
<p style="top:567.4pt;left:51.0pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Safety of MSC</span></p>
<p style="top:593.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">All studies described the MSC-based cell therapy as safe with no</span></p>
<p style="top:605.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">reported serious adverse events. The loss of experimental ani-</span></p>
<p style="top:618.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">mals (</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 9) was due to unrelated events such as death during</span></p>
<p style="top:630.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">anaesthesia and complications of producing the bony defect.</span></p>
<p style="top:642.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The case reports revealed no adverse events or complications.</span></p>
<p style="top:667.7pt;left:51.0pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Description of the Animal Models</span></p>
<p style="top:693.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Four articles investigated the safety and efficacy of MSCs for</span></p>
<p style="top:705.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">mandibular ORN in a total of 139 animals (intervention</span></p>
<p style="top:430.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">groups</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313"> n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 49) of different species (Table</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">). The research</span></p>
<p style="top:442.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">groups used variations of the same model to mimic ORN, by</span></p>
<p style="top:455.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">radiating the hemimandible with 20</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">30 Gy, followed by tooth</span></p>
<p style="top:467.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">extraction to induce a bone defect (Table</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">). The source of the</span></p>
<p style="top:480.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs also varied between the studies (Table</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">).</span></p>
<p style="top:505.9pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">The Effect of MSCs on Osseous Healing of the</span></p>
<p style="top:518.3pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Mandible in Animal Model ORN</span></p>
<p style="top:544.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Four animal studies (</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 139) investigated the effect of MSCs</span></p>
<p style="top:556.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">on osseous healing in mandibular ORN (Table</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:568.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Primary outcome of the studies differed. All studies could</span></p>
<p style="top:581.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">demonstrate an increase of osseous healing in animals treated</span></p>
<p style="top:593.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">with MSCs for ORN. Based on micro-CT results, two studies</span></p>
<p style="top:606.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 89) showed a significant increase of the bone volume</span></p>
<p style="top:618.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(BV) for animals treated with MSCs compared to untreated</span></p>
<p style="top:631.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">animals [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Two studies found a significant increase of</span></p>
<p style="top:643.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the bone mineral density (BMD) compared to untreated ani-</span></p>
<p style="top:656.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">mals [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">15</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Finally, one study found a significant increase</span></p>
<p style="top:668.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">in bone volume/tissue volume (BV/TV) compared to untreat-</span></p>
<p style="top:681.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ed animals [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">16</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:693.4pt;left:317.5pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Histologically, all studies found increased bone formation</span></p>
<p style="top:705.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">in the MSC groups compared to controls. Janus et al. found a</span></p>
<img style="position:absolute;transform:matrix(.31992526,0,-0,.31995953,-133.41266,-430.7393)" src="data:image/png;base64,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">
<p style="top:56.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Fig. 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> PRISMA chart showing</span></p>
<p style="top:66.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">the screening process for the</span></p>
<p style="top:76.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">selection of eligible studies</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1210</span></p>
<p style="top:33.5pt;left:400.1pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:707.1pt;left:57.8pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Table 1</span></p>
<p style="top:672.1pt;left:57.9pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Animal ORN models</span></p>
<p style="top:707.1pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Author (Year)</span></p>
<p style="top:643.7pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Animals</span></p>
<p style="top:570.4pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Origin of MSCs</span></p>
<p style="top:497.1pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Intervention</span></p>
<p style="top:411.1pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Groups</span></p>
<p style="top:332.8pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Method for ORN</span></p>
<p style="top:265.5pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Focus of interest</span></p>
<p style="top:192.8pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Statistic tests</span></p>
<p style="top:106.8pt;left:76.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Study design</span></p>
<p style="top:707.9pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Park HS. et al.</span></p>
<p style="top:699.4pt;left:106.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(2017) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#0000ff">15</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">]</span></p>
<p style="top:644.6pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Adult male Sprague</span></p>
<p style="top:636.0pt;left:106.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Dawley rats</span></p>
<p style="top:636.0pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(250 g</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:7.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">300 g)</span></p>
<p style="top:636.0pt;left:123.5pt;line-height:7.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 36</span></p>
<p style="top:571.2pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Tonsil derived-MSCs</span></p>
<p style="top:562.7pt;left:106.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(TMSCs) from a</span></p>
<p style="top:562.7pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">5-year old boy who</span></p>
<p style="top:562.7pt;left:124.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">underwent</span></p>
<p style="top:562.7pt;left:133.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tonsillectomy.</span></p>
<p style="top:571.2pt;left:141.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Xenograft</span></p>
<p style="top:497.9pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Control group received only</span></p>
<p style="top:489.4pt;left:106.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tooth extraction, no</span></p>
<p style="top:489.4pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">radiation. The other rats</span></p>
<p style="top:489.4pt;left:124.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">are divided into 5 groups.</span></p>
<p style="top:489.4pt;left:133.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">First group is the ORN</span></p>
<p style="top:489.4pt;left:141.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">group, receiving both</span></p>
<p style="top:489.4pt;left:150.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">radiation and tooth</span></p>
<p style="top:489.4pt;left:159.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">extraction, but no</span></p>
<p style="top:489.4pt;left:168.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">treatment. Two other</span></p>
<p style="top:489.4pt;left:177.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">groups underwent same</span></p>
<p style="top:489.4pt;left:186.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">procedure but received</span></p>
<p style="top:489.4pt;left:195.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">the received matrigel</span></p>
<p style="top:489.4pt;left:204.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">directly into the wound of</span></p>
<p style="top:489.4pt;left:213.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">the tooth extractions, one</span></p>
<p style="top:489.4pt;left:222.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">group received it</span></p>
<p style="top:489.4pt;left:231.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">immediately, and one</span></p>
<p style="top:489.4pt;left:240.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">after 4 weeks. Same for</span></p>
<p style="top:489.4pt;left:249.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">the last two groups,</span></p>
<p style="top:489.4pt;left:258.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">although they received</span></p>
<p style="top:489.4pt;left:267.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">the TMSCs instead of</span></p>
<p style="top:489.4pt;left:276.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">only matrigel. Animals</span></p>
<p style="top:489.4pt;left:285.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">were killed 8 weeks after</span></p>
<p style="top:489.4pt;left:294.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">receiving matrigel</span></p>
<p style="top:489.4pt;left:303.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">or TMSCs.</span></p>
<p style="top:412.0pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">1. Control group. Tooth</span></p>
<p style="top:403.5pt;left:106.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">extraction. (TE) n = 3</span></p>
<p style="top:412.0pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">2. Radiation therapy</span></p>
<p style="top:403.5pt;left:123.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(RT) + TE / ORN</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 4</span></p>
<p style="top:412.0pt;left:133.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">3. RT + TE + Matrigel</span></p>
<p style="top:403.5pt;left:141.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">application</span></p>
<p style="top:403.5pt;left:150.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">immediately.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 9</span></p>
<p style="top:412.0pt;left:159.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4. RT + TE + TMSCs</span></p>
<p style="top:403.5pt;left:168.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">immediately.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 6</span></p>
<p style="top:412.0pt;left:177.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">5. RT + TE + Matrigel</span></p>
<p style="top:403.5pt;left:186.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4 weeks post. n = 6</span></p>
<p style="top:412.0pt;left:195.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">6. RT + TE + TMSCs</span></p>
<p style="top:403.5pt;left:204.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4 weeks post.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 8</span></p>
<p style="top:333.7pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Left mandibular body</span></p>
<p style="top:325.2pt;left:106.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">irradiated with</span></p>
<p style="top:325.2pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">single dose 20Gy.</span></p>
<p style="top:325.2pt;left:124.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">One week later,</span></p>
<p style="top:325.2pt;left:133.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">three left molars</span></p>
<p style="top:325.2pt;left:141.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">are extracted to</span></p>
<p style="top:325.2pt;left:150.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">induce ORN.</span></p>
<p style="top:266.4pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">A study of the effect of</span></p>
<p style="top:257.9pt;left:106.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tonsil derived MSCs</span></p>
<p style="top:257.9pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">for the treatment of</span></p>
<p style="top:257.9pt;left:124.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN. It is also a</span></p>
<p style="top:257.9pt;left:133.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">study of the effect of</span></p>
<p style="top:257.9pt;left:141.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">immediate</span></p>
<p style="top:257.9pt;left:150.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">application of the</span></p>
<p style="top:257.9pt;left:159.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">TMSCs, versus</span></p>
<p style="top:257.9pt;left:168.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">application 4 weeks</span></p>
<p style="top:257.9pt;left:177.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">post teeth extraction.</span></p>
<p style="top:193.6pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Micro-CT, as well as</span></p>
<p style="top:185.1pt;left:106.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">histological analysis were</span></p>
<p style="top:185.1pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">conducted. The</span></p>
<p style="top:185.1pt;left:124.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">micro-CTs were analysed</span></p>
<p style="top:185.1pt;left:133.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">using the Mann-Whitney</span></p>
<p style="top:185.1pt;left:141.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">U test, to test for</span></p>
<p style="top:185.1pt;left:150.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">significance of data. The</span></p>
<p style="top:185.1pt;left:159.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">histological analyses</span></p>
<p style="top:185.1pt;left:168.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">were not analysed</span></p>
<p style="top:185.1pt;left:177.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">statistically.</span></p>
<p style="top:107.6pt;left:97.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Controlled trial. The</span></p>
<p style="top:99.1pt;left:106.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">analysis of the</span></p>
<p style="top:99.1pt;left:115.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">micro-CT scans</span></p>
<p style="top:99.1pt;left:124.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">was done</span></p>
<p style="top:99.1pt;left:133.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">blinded.</span></p>
<p style="top:707.9pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Jin IG et al.</span></p>
<p style="top:699.4pt;left:321.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(2015) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">]</span></p>
<p style="top:644.6pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Seven weeks old</span></p>
<p style="top:636.0pt;left:321.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Sprague-Dawley</span></p>
<p style="top:636.0pt;left:330.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">rats. Avg. weight</span></p>
<p style="top:636.0pt;left:339.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">205 g. (Originally</span></p>
<p style="top:636.0pt;left:348.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">114 animals, but 49</span></p>
<p style="top:636.0pt;left:357.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">lost during</span></p>
<p style="top:636.0pt;left:366.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">development of</span></p>
<p style="top:636.0pt;left:374.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN).</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> N</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 65.</span></p>
<p style="top:571.2pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Bone marrow</span></p>
<p style="top:562.7pt;left:321.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">mesenchymal stem</span></p>
<p style="top:562.7pt;left:330.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">cells cultured from</span></p>
<p style="top:562.7pt;left:339.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">bone marrow</span></p>
<p style="top:562.7pt;left:348.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">aspirate from</span></p>
<p style="top:562.7pt;left:357.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">rat tibias.</span></p>
<p style="top:571.2pt;left:366.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Allogenous.</span></p>
<p style="top:497.9pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Rats were split into two</span></p>
<p style="top:489.4pt;left:321.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">overall groups apart from</span></p>
<p style="top:489.4pt;left:330.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">control and pilot</span></p>
<p style="top:489.4pt;left:339.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">experiments group.</span></p>
<p style="top:489.4pt;left:348.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Group 1 received the</span></p>
<p style="top:489.4pt;left:357.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">implant of hydrogel</span></p>
<p style="top:489.4pt;left:366.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">loaded with rat MSCs</span></p>
<p style="top:489.4pt;left:375.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(rMSCs) or</span></p>
<p style="top:489.4pt;left:384.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">bone-morphogenetic</span></p>
<p style="top:489.4pt;left:393.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">protein-2 (BMP-2) or a</span></p>
<p style="top:489.4pt;left:402.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">combination immediately</span></p>
<p style="top:489.4pt;left:410.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">after producing the bone</span></p>
<p style="top:489.4pt;left:419.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">defect. Group 2 received</span></p>
<p style="top:489.4pt;left:428.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">the loaded hydrogel</span></p>
<p style="top:489.4pt;left:437.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4 weeks postoperatively</span></p>
<p style="top:489.4pt;left:446.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">while also undergoing</span></p>
<p style="top:489.4pt;left:455.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">curettage. The follow-up</span></p>
<p style="top:489.4pt;left:464.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">period for the rats were</span></p>
<p style="top:489.4pt;left:473.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4 weeks after the</span></p>
<p style="top:489.4pt;left:482.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">insertion of the hydrogel</span></p>
<p style="top:489.4pt;left:491.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">i.e. 4 weeks</span></p>
<p style="top:489.4pt;left:500.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">postoperatively for the</span></p>
<p style="top:489.4pt;left:509.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">rats in group 1 and</span></p>
<p style="top:489.4pt;left:518.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">8 weeks for group 2.</span></p>
<p style="top:412.0pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">1. Control group, surgery,</span></p>
<p style="top:403.5pt;left:321.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">but no radiation. N = 6</span></p>
<p style="top:412.0pt;left:330.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">2. Pilot experiments</span></p>
<p style="top:403.5pt;left:339.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">group, to determine</span></p>
<p style="top:403.5pt;left:348.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">doses and confirm</span></p>
<p style="top:403.5pt;left:357.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN development.</span></p>
<p style="top:403.5pt;left:365.5pt;line-height:7.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313">N</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 9</span></p>
<p style="top:412.0pt;left:375.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">3. Group 1, radiation, and</span></p>
<p style="top:403.5pt;left:384.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">defect formation.</span></p>
<p style="top:403.5pt;left:392.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Received the hydrogel</span></p>
<p style="top:403.5pt;left:402.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">immediately.</span></p>
<p style="top:403.5pt;left:410.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Subdivisions</span></p>
<p style="top:403.5pt;left:419.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">a-e below.</span></p>
<p style="top:412.0pt;left:428.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4. Group 2, same as gr. 1,</span></p>
<p style="top:403.5pt;left:437.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">but received hydrogel</span></p>
<p style="top:403.5pt;left:446.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4 weeks post-surgery.</span></p>
<p style="top:412.0pt;left:455.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Subdivisions a-e below.</span></p>
<p style="top:412.0pt;left:464.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">a: Defect formation only</span></p>
<p style="top:403.5pt;left:473.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 5 each grp.)</span></p>
<p style="top:412.0pt;left:482.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">b: Hydrogel only</span></p>
<p style="top:403.5pt;left:491.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(n = 5 each grp.)</span></p>
<p style="top:412.0pt;left:500.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">c: Hydrogel loaded</span></p>
<p style="top:403.5pt;left:509.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">with rMSCs</span></p>
<p style="top:403.5pt;left:518.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(n = 5 each grp.)</span></p>
<p style="top:333.7pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Single dose of 30 Gy</span></p>
<p style="top:325.2pt;left:321.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">administered to the</span></p>
<p style="top:325.2pt;left:330.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">right mandible.</span></p>
<p style="top:325.2pt;left:339.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">One week later</span></p>
<p style="top:325.2pt;left:348.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">three right</span></p>
<p style="top:325.2pt;left:357.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">mandibular molars</span></p>
<p style="top:325.2pt;left:366.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">were extracted,</span></p>
<p style="top:325.2pt;left:375.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and a bony defect</span></p>
<p style="top:325.2pt;left:384.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">created surgically</span></p>
<p style="top:325.2pt;left:393.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">to induce the ORN.</span></p>
<p style="top:266.4pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">The study investigates</span></p>
<p style="top:257.9pt;left:321.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">the effect of MSCs,</span></p>
<p style="top:257.9pt;left:330.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">BMP-2 and a</span></p>
<p style="top:257.9pt;left:339.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">combination, on the</span></p>
<p style="top:257.9pt;left:348.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">osseous healing in</span></p>
<p style="top:257.9pt;left:357.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN, at two</span></p>
<p style="top:257.9pt;left:366.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">different</span></p>
<p style="top:257.9pt;left:375.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">administration times.</span></p>
<p style="top:193.6pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">The normality of distribution</span></p>
<p style="top:185.1pt;left:321.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">for the data confirmed</span></p>
<p style="top:185.1pt;left:330.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">with the</span></p>
<p style="top:185.1pt;left:339.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Kolmogorov-Smirnov</span></p>
<p style="top:185.1pt;left:348.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">test. Two-way analysis of</span></p>
<p style="top:185.1pt;left:357.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">variance (ANOVA) with</span></p>
<p style="top:185.1pt;left:366.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Bonferroni correction</span></p>
<p style="top:185.1pt;left:375.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">was used to analyse</span></p>
<p style="top:185.1pt;left:384.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">effects of application time</span></p>
<p style="top:185.1pt;left:393.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and material. One-way</span></p>
<p style="top:185.1pt;left:402.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ANOVA was used to</span></p>
<p style="top:185.1pt;left:410.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">analyse the differences</span></p>
<p style="top:185.1pt;left:419.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">within the groups.</span></p>
<p style="top:185.1pt;left:428.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Groups with abnormal</span></p>
<p style="top:185.1pt;left:437.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">distribution had the</span></p>
<p style="top:185.1pt;left:446.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Kruskal-Wallis test run to</span></p>
<p style="top:185.1pt;left:455.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">compare CT data. Results</span></p>
<p style="top:185.1pt;left:464.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">considered significant at</span></p>
<p style="top:185.1pt;left:473.2pt;line-height:7.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313">p</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> value of &lt;0,05.</span></p>
<p style="top:107.6pt;left:312.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Controlled trial</span></p>
<p style="top:33.5pt;left:528.3pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1211</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:707.1pt;left:53.5pt;line-height:8.5pt"><span style="font-family:RtdftmPnpnfcAdvTTb8864cc,serif;font-size:8.5pt;color:#131313">Table 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> (continued)</span></p>
<p style="top:707.1pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Author (Year)</span></p>
<p style="top:643.7pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Animals</span></p>
<p style="top:570.4pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Origin of MSCs</span></p>
<p style="top:497.1pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Intervention</span></p>
<p style="top:411.1pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Groups</span></p>
<p style="top:332.8pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Method for ORN</span></p>
<p style="top:265.5pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Focus of interest</span></p>
<p style="top:192.8pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Statistic tests</span></p>
<p style="top:106.8pt;left:72.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Study design</span></p>
<p style="top:412.0pt;left:92.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">d: Hydrogel loaded</span></p>
<p style="top:403.5pt;left:101.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">with BMP-2</span></p>
<p style="top:403.5pt;left:110.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(n = 5 each grp.)</span></p>
<p style="top:412.0pt;left:119.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">e: Hydrogel loaded with</span></p>
<p style="top:403.5pt;left:128.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">both rMSCs</span></p>
<p style="top:403.5pt;left:137.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and BMP-2.</span></p>
<p style="top:403.5pt;left:146.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(n = 5 each grp.)</span></p>
<p style="top:707.9pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Janus JR et al.</span></p>
<p style="top:699.4pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(2017) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#0000ff">14</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">]</span></p>
<p style="top:644.6pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">7 weeks old athymic</span></p>
<p style="top:636.0pt;left:163.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">nude rats.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> N</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 23.</span></p>
<p style="top:571.2pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Human adipose-derived</span></p>
<p style="top:562.7pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">mesenchymal stem</span></p>
<p style="top:562.7pt;left:173.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">cells (ADSCs)</span></p>
<p style="top:562.7pt;left:182.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">donated by people</span></p>
<p style="top:562.7pt;left:191.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">who had restorative</span></p>
<p style="top:562.7pt;left:200.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">surgery for ORN.</span></p>
<p style="top:571.2pt;left:209.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Xenograft.</span></p>
<p style="top:497.9pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Control group received no</span></p>
<p style="top:489.4pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">radiation. The other 4</span></p>
<p style="top:489.4pt;left:173.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">groups received radiation</span></p>
<p style="top:489.4pt;left:182.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and tooth extraction</span></p>
<p style="top:489.4pt;left:191.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">7 days later. 35 days post</span></p>
<p style="top:489.4pt;left:200.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">irradiation injections of</span></p>
<p style="top:489.4pt;left:209.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">either saline, ADSCs,</span></p>
<p style="top:489.4pt;left:218.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Platelet Rich Plasma/</span></p>
<p style="top:489.4pt;left:227.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Collagen (PRP/COL), or</span></p>
<p style="top:489.4pt;left:236.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">combinations thereof,</span></p>
<p style="top:489.4pt;left:245.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">were done. 28 days post</span></p>
<p style="top:489.4pt;left:254.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">injections the rats were</span></p>
<p style="top:489.4pt;left:263.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">sacrificed for analysis.</span></p>
<p style="top:412.0pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">1. Control group, no</span></p>
<p style="top:403.5pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">irradiation n = 4</span></p>
<p style="top:412.0pt;left:173.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">2. Saline injections n = 5</span></p>
<p style="top:412.0pt;left:182.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">3. Saline + ADSCs n = 5</span></p>
<p style="top:412.0pt;left:191.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4. PRP/COL n = 4 (loss of</span></p>
<p style="top:403.5pt;left:200.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">1 animal)</span></p>
<p style="top:412.0pt;left:209.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">5. ADSCs + PRP/COL</span></p>
<p style="top:403.5pt;left:218.2pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">n = 5</span></p>
<p style="top:333.7pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Left mandible</span></p>
<p style="top:325.2pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">irradiated with</span></p>
<p style="top:325.2pt;left:173.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">single dose 20 Gy.</span></p>
<p style="top:325.2pt;left:182.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">7 days later,</span></p>
<p style="top:325.2pt;left:191.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">second left molar</span></p>
<p style="top:325.2pt;left:200.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">was extracted to</span></p>
<p style="top:325.2pt;left:209.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">induce ORN.</span></p>
<p style="top:266.4pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">A study to investigate</span></p>
<p style="top:257.9pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">the regenerative</span></p>
<p style="top:257.9pt;left:173.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and restorative</span></p>
<p style="top:257.9pt;left:182.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">properties of ADSCs</span></p>
<p style="top:257.9pt;left:191.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">in a validated model</span></p>
<p style="top:257.9pt;left:200.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">for ORN.</span></p>
<p style="top:193.6pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Initial Chi-square analysis,</span></p>
<p style="top:185.1pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">followed by 2-tailed</span></p>
<p style="top:185.1pt;left:173.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">t-tests for unpaired</span></p>
<p style="top:185.1pt;left:182.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">samples for p value</span></p>
<p style="top:185.1pt;left:191.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">&lt;0,05. Pathologists were</span></p>
<p style="top:185.1pt;left:200.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">blinded for histological</span></p>
<p style="top:185.1pt;left:209.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">analysis.</span></p>
<p style="top:107.6pt;left:155.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Controlled trial.</span></p>
<p style="top:99.1pt;left:164.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Histological</span></p>
<p style="top:99.1pt;left:173.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">analysis was</span></p>
<p style="top:99.1pt;left:182.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">done blinded.</span></p>
<p style="top:707.9pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Xu J et al.</span></p>
<p style="top:699.4pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(2012) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#0000ff">16</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">]</span></p>
<p style="top:644.6pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Inbred miniature pigs,</span></p>
<p style="top:636.0pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">7</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:7.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">8 months old,</span></p>
<p style="top:636.0pt;left:289.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">25</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:7.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">30 kg.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> N</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 15.</span></p>
<p style="top:571.2pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Bone marrow</span></p>
<p style="top:562.7pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">mesenchymal</span></p>
<p style="top:562.7pt;left:290.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">stromal cells</span></p>
<p style="top:562.7pt;left:298.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(BMMSCs) were</span></p>
<p style="top:562.7pt;left:307.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">harvested and</span></p>
<p style="top:562.7pt;left:316.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">cultured from the</span></p>
<p style="top:562.7pt;left:325.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ilium of the</span></p>
<p style="top:562.7pt;left:334.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">irradiated pigs</span></p>
<p style="top:562.7pt;left:343.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">5 months post</span></p>
<p style="top:562.7pt;left:352.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">radiation.</span></p>
<p style="top:571.2pt;left:361.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Autologous.</span></p>
<p style="top:497.9pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">No radiation in control</span></p>
<p style="top:489.4pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">group. The remaining</span></p>
<p style="top:489.4pt;left:289.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">pigs received irradiation</span></p>
<p style="top:489.4pt;left:298.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">of the mandibular body,</span></p>
<p style="top:489.4pt;left:307.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and two months later had</span></p>
<p style="top:489.4pt;left:316.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tooth extraction. The</span></p>
<p style="top:489.4pt;left:325.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">treatment group received</span></p>
<p style="top:489.4pt;left:334.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">autologous BMMSCs +</span></p>
<p style="top:489.4pt;left:343.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">HA/TCP 6 months post</span></p>
<p style="top:489.4pt;left:352.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">radiation. The control</span></p>
<p style="top:489.4pt;left:361.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">group received only</span></p>
<p style="top:489.4pt;left:370.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">HA/TCP at the same</span></p>
<p style="top:489.4pt;left:379.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">time. Six months</span></p>
<p style="top:489.4pt;left:388.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">post-transplant i.e. 1 year</span></p>
<p style="top:489.4pt;left:397.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">after radiation.</span></p>
<p style="top:412.0pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">1. Control group.</span></p>
<p style="top:403.5pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Irradiation, no tooth</span></p>
<p style="top:403.5pt;left:289.4pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">extraction.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> N</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 3</span></p>
<p style="top:412.0pt;left:298.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">2. Sample group, with</span></p>
<p style="top:403.5pt;left:307.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tooth extractions, for</span></p>
<p style="top:403.5pt;left:316.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">observations at set</span></p>
<p style="top:403.5pt;left:325.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">points. N = 3</span></p>
<p style="top:412.0pt;left:334.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">3. Treatment group,</span></p>
<p style="top:403.5pt;left:343.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">transplant of</span></p>
<p style="top:403.5pt;left:352.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">BMMSCs with</span></p>
<p style="top:403.5pt;left:361.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">hydroxyapatite/</span></p>
<p style="top:403.5pt;left:370.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tricalcium phosphate</span></p>
<p style="top:403.5pt;left:379.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(HA/TCP).</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> N</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 5</span></p>
<p style="top:412.0pt;left:388.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">4. Control group with</span></p>
<p style="top:403.5pt;left:397.5pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">only HA/TCP</span></p>
<p style="top:403.5pt;left:406.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">implants.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> N</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> = 4</span></p>
<p style="top:333.7pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Mandibular body</span></p>
<p style="top:325.2pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">irradiated with a</span></p>
<p style="top:325.2pt;left:289.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">single dose of</span></p>
<p style="top:325.2pt;left:298.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">25 Gy. First molar</span></p>
<p style="top:325.2pt;left:307.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">extracted 2 months</span></p>
<p style="top:325.2pt;left:316.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">post irradiation.</span></p>
<p style="top:266.4pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">A study of the effect</span></p>
<p style="top:257.9pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">of autologous</span></p>
<p style="top:257.9pt;left:289.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">implantation of</span></p>
<p style="top:257.9pt;left:298.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">BMMSCs in a swine</span></p>
<p style="top:257.9pt;left:307.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN model.</span></p>
<p style="top:193.6pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Data was analysed</span></p>
<p style="top:185.1pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">statistically with a</span></p>
<p style="top:185.1pt;left:289.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">one-way analysis of</span></p>
<p style="top:185.1pt;left:298.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">variance (ANOVA), with</span></p>
<p style="top:185.1pt;left:307.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">values compared with</span></p>
<p style="top:185.1pt;left:316.3pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">control groups.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:7.5pt;color:#131313"> p</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313"> value of</span></p>
<p style="top:185.1pt;left:325.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">&lt;0.05 was significant.</span></p>
<p style="top:185.1pt;left:334.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Adjusted by the</span></p>
<p style="top:185.1pt;left:343.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Bonferroni method for</span></p>
<p style="top:185.1pt;left:352.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">multiple comparisons.</span></p>
<p style="top:107.6pt;left:272.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Randomly</span></p>
<p style="top:99.1pt;left:281.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">controlled trial.</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1212</span></p>
<p style="top:33.5pt;left:400.1pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:58.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">significant decrease in osteoclasts in MSC, MSC + platelet-</span></p>
<p style="top:70.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">rich-plasma (PRP)/collagen (COL) group, and PRP/COL</span></p>
<p style="top:83.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">groups when compared to saline injections only. They also</span></p>
<p style="top:95.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">found a significant increase in the number of osteoblasts in</span></p>
<p style="top:108.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSC + PRP/COL and PRP/COL group, but not in MSC</span></p>
<p style="top:120.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">group [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:144.7pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">The Administration Time of the MSCs for ORN</span></p>
<p style="top:170.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Two studies with rats (</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:10.0pt;color:#131313">n</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> = 101) investigated how the</span></p>
<p style="top:182.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">timing of MSC administration altered the outcome of</span></p>
<p style="top:195.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ORN [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">15</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Both applied the MSCs either immediately</span></p>
<p style="top:207.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">after producing the bony defect or four weeks later. Jin</span></p>
<p style="top:220.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">et al. [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] found that the application of allogenic rat BM-</span></p>
<p style="top:232.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs only had a significant improvement in BV and BMD</span></p>
<p style="top:245.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">when applied four weeks after tooth extraction. In contrast,</span></p>
<p style="top:257.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Park et al. [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">15</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] found that only immediate application of</span></p>
<p style="top:270.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">human tonsillar-derived MSCs after extracting teeth</span></p>
<p style="top:282.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">showed a significant improvement in BMD.</span></p>
<p style="top:306.6pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">The Effect of MSCs on Mandibular ORN in Human Case</span></p>
<p style="top:319.1pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Studies</span></p>
<p style="top:344.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Manimaran et al. [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">36</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] introduced a case study with two pa-</span></p>
<p style="top:357.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tients with confirmed ORN diagnosis treated either with BM</span></p>
<p style="top:369.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">aspirate concentrate (BMAC) or dental pulp stem cells</span></p>
<p style="top:382.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(DPSCs). The first patient was a 48-year-old male with recur-</span></p>
<p style="top:394.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ring symptoms of advanced ORN over a period of 1.5 years</span></p>
<p style="top:407.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(with chronic osteomyelitis and a suspected pathological frac-</span></p>
<p style="top:419.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ture) following radiotherapy for carcinoma of the soft palate in</span></p>
<p style="top:432.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">combination with tooth extraction. After curettage, this patient</span></p>
<p style="top:444.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">received autologous BMACs via local injection as well as</span></p>
<p style="top:456.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">mixed in a hydroxyapatite/tricalcium phosphate (HA/TCP)</span></p>
<p style="top:469.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">matrix. Two months later the patient showed signs of im-</span></p>
<p style="top:481.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">provement with early bone formation as demonstrated on ra-</span></p>
<p style="top:494.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">diographs, by pain reduction, and cessation of discharge from</span></p>
<p style="top:506.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the intraoral lesion. Six months after the treatment, there was a</span></p>
<p style="top:519.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">resolution of the suspected pathological fracture. Complete</span></p>
<p style="top:531.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">bone remodeling was noticed in radiographs after one year,</span></p>
<p style="top:544.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and two years after treatment the patient was still asymptom-</span></p>
<p style="top:556.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">atic with no apparent adverse effects. The second patient, a 47-</span></p>
<p style="top:568.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">year-old male, with a history of radiotherapy for oral cancer,</span></p>
<p style="top:581.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">presented with signs of advanced ORN. The patient was treat-</span></p>
<p style="top:593.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ed with allogenic DPSCs, extracted from teeth removed for</span></p>
<p style="top:606.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">orthodontic management. Following surgical curettage, un-</span></p>
<p style="top:618.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">specified dose of DPSCs in PRP combined with TCP as a</span></p>
<p style="top:631.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">scaffold was inserted into the defect, and DPSCs in PRP were</span></p>
<p style="top:643.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">also injected into nearby soft tissue. Two months later bone</span></p>
<p style="top:656.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">formation was appreciable, and six months later, clearly no-</span></p>
<p style="top:668.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ticeable on radiographs. Further follow-up was not reported.</span></p>
<p style="top:681.0pt;left:317.5pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Mendonca et al. [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">37</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] presented a case study including one</span></p>
<p style="top:693.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">63-year-old male with severe advanced ORN including intra-</span></p>
<p style="top:705.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and extraoral fistulas. Before surgical curettage of necrotic</span></p>
<p style="top:707.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Table 2</span></p>
<p style="top:672.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Human case studies</span></p>
<p style="top:707.1pt;left:90.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Author</span></p>
<p style="top:632.0pt;left:90.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Patients</span></p>
<p style="top:556.8pt;left:90.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Origin of MSCs</span></p>
<p style="top:481.7pt;left:90.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Intervention</span></p>
<p style="top:326.9pt;left:90.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">ORN diagnosis</span></p>
<p style="top:221.9pt;left:90.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Focus of interest</span></p>
<p style="top:116.8pt;left:90.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Statistic tests</span></p>
<p style="top:707.9pt;left:111.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Mendonca JJ et al.</span></p>
<p style="top:699.4pt;left:120.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(2010) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#0000ff">37</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">]</span></p>
<p style="top:632.8pt;left:111.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">3 Patients, but only one</span></p>
<p style="top:624.3pt;left:120.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">diagnosed with</span></p>
<p style="top:624.3pt;left:129.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN, one</span></p>
<p style="top:624.3pt;left:138.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">63-year-old male</span></p>
<p style="top:624.3pt;left:146.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">subject. N = 1</span></p>
<p style="top:557.6pt;left:111.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Autologous MSCs/</span></p>
<p style="top:549.1pt;left:120.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tissue repair cells,</span></p>
<p style="top:549.1pt;left:129.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">obtained from</span></p>
<p style="top:549.1pt;left:138.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">patient</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:7.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">s</span></p>
<p style="top:549.1pt;left:146.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">posterior ileum.</span></p>
<p style="top:482.5pt;left:111.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Following the development of advanced</span></p>
<p style="top:474.0pt;left:120.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">osteoradionecrosis, this patient received an</span></p>
<p style="top:474.0pt;left:129.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">autologous transplantation of BMMSCs</span></p>
<p style="top:474.0pt;left:138.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">harvested from the posterior ileum. These were</span></p>
<p style="top:474.0pt;left:146.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">then concentrated, cultured and prepared for</span></p>
<p style="top:474.0pt;left:155.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">transplantation with platelet-rich and poor plasma</span></p>
<p style="top:474.0pt;left:164.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and HA/TCP. The prepared cells were then</span></p>
<p style="top:474.0pt;left:173.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">injected into the ORN defect, and surrounding</span></p>
<p style="top:474.0pt;left:182.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tissue, following a debridement of necrotic tissue.</span></p>
<p style="top:327.7pt;left:111.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Patient diagnosed with advanced</span></p>
<p style="top:319.2pt;left:120.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN with pathological</span></p>
<p style="top:319.2pt;left:129.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">fracture, following radiation</span></p>
<p style="top:319.2pt;left:138.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">treatment of tonsillar cancer,</span></p>
<p style="top:319.2pt;left:146.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and a following tooth</span></p>
<p style="top:319.2pt;left:155.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">extraction. HBO chamber,</span></p>
<p style="top:319.2pt;left:164.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">antibiotics and other treatment</span></p>
<p style="top:319.2pt;left:173.9pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">tried.</span></p>
<p style="top:222.7pt;left:111.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Case study of the effects</span></p>
<p style="top:214.1pt;left:120.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">of MSCs in the treatment of</span></p>
<p style="top:214.1pt;left:129.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN and other advanced</span></p>
<p style="top:214.1pt;left:138.0pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">craniofacial diseases.</span></p>
<p style="top:117.6pt;left:111.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">No statistical data, as it</span></p>
<p style="top:109.1pt;left:120.1pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">is a case study.</span></p>
<p style="top:707.9pt;left:191.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Manimaran K. et al.</span></p>
<p style="top:699.4pt;left:200.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">(2014) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#0000ff">36</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">]</span></p>
<p style="top:632.8pt;left:191.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">One 48-year-old male</span></p>
<p style="top:624.3pt;left:200.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">and a 47-year-old</span></p>
<p style="top:624.3pt;left:209.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">male subject. N = 2</span></p>
<p style="top:557.6pt;left:191.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">One case (1) with</span></p>
<p style="top:549.1pt;left:200.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">autologous bone</span></p>
<p style="top:549.1pt;left:209.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">marrow aspirate</span></p>
<p style="top:549.1pt;left:218.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">conc. (BMAC).</span></p>
<p style="top:549.1pt;left:227.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Second case (2) is</span></p>
<p style="top:549.1pt;left:236.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">allogenic dental pulp</span></p>
<p style="top:549.1pt;left:245.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">stem cells (DPSCs).</span></p>
<p style="top:482.5pt;left:191.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">Case 1 patient received autologous BMMSCs,</span></p>
<p style="top:474.0pt;left:200.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">harvested from his iliac crest, this was then</span></p>
<p style="top:474.0pt;left:209.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">concentrated and injected into the socket around</span></p>
<p style="top:474.0pt;left:218.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">his bone defect. Case 2 patient received allogenic</span></p>
<p style="top:474.0pt;left:227.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">DPSCs from extracted teeth. Stem cell graft</span></p>
<p style="top:474.0pt;left:236.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">consisting of PRP and alloplastic graft as scaffold</span></p>
<p style="top:474.0pt;left:245.6pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">was inserted into the defect.</span></p>
<p style="top:327.7pt;left:191.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">ORN diagnosed in the two</span></p>
<p style="top:319.2pt;left:200.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">patients, as they both have had</span></p>
<p style="top:319.2pt;left:209.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">oropharyngeal cancers.</span></p>
<p style="top:222.7pt;left:191.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">A case study of the effect</span></p>
<p style="top:214.1pt;left:200.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">of MSCs as a</span></p>
<p style="top:214.1pt;left:209.7pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">treatment for ORN.</span></p>
<p style="top:117.6pt;left:191.8pt;line-height:7.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.5pt;color:#131313">No statistical data.</span></p>
<p style="top:33.5pt;left:528.3pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1213</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:58.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tissue, the patient was treated with an injection of 5 &#xd7; 10</span><sup><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:7.0pt;color:#131313">8</span></sup></p>
<p style="top:70.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">culture-expanded BM-derived total nuclear cells (TNCs) of</span></p>
<p style="top:83.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">which approx. 36% expressed CD90 [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">22</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. However, approx.</span></p>
<p style="top:95.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">67% of TNCs also expressed CD45, which is a common leu-</span></p>
<p style="top:108.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cocyte antigen that should be negative in MSCs. The cells</span></p>
<p style="top:120.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">were mixed with PRP and platelet-poor plasma and HA/</span></p>
<p style="top:133.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">TCP, forming a bioactive matrix. As another temporary scaf-</span></p>
<p style="top:145.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">fold, a membrane made by compressing platelet-poor plasma</span></p>
<p style="top:158.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and injected with cells, was used. Cells were also inoculated</span></p>
<p style="top:170.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">into nearby soft tissues. Three months post-operatively the</span></p>
<p style="top:182.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">patient showed signs of osteogenesis on CT-scans. During a</span></p>
<p style="top:195.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">dental prosthesis procedure, a bone biopsy was performed. It</span></p>
<p style="top:207.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">showed a pure cortical morphology and osteoblast/osteoclast</span></p>
<p style="top:220.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">activity. Twenty-months post-operatively, the patient reported</span></p>
<p style="top:232.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">no complications nor sequelae.</span></p>
<p style="top:256.8pt;left:51.0pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Risk of Bias</span></p>
<p style="top:282.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The animal studies were assessed using SYRCLEs guidelines</span></p>
<p style="top:294.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and risk of bias tool with eight questions to determine poten-</span></p>
<p style="top:307.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tial biases for animal studies [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">38</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. The assessment revealed</span></p>
<p style="top:319.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">risk of bias for all studies: particularly selection bias, as none</span></p>
<p style="top:332.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">of the studies described how the randomization of</span></p>
<p style="top:344.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">intervention/control groups was performed (Fig.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 2</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">).</span></p>
<p style="top:357.2pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">None of the studies reported blinding of investigators, and</span></p>
<p style="top:369.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">none reported random housing. All of the studies had a low</span></p>
<p style="top:382.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">risk of bias concerning attrition and detection bias, but Xu</span></p>
<p style="top:394.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">et al. and Jin et al. did not report blinding of the outcome</span></p>
<p style="top:407.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">assessment [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">16</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Case reports have a great risk of publica-</span></p>
<p style="top:419.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tion-bias, as cases with negative results would most likely not</span></p>
<p style="top:432.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">be published, and there are no requirements to report if such</span></p>
<p style="top:444.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cases exist.</span></p>
<p style="top:480.1pt;left:51.0pt;line-height:12.0pt"><span style="font-family:GnfgftRwwvyhAdvTTaf7f9f4,serif;font-size:12.0pt;color:#131313">Discussion</span></p>
<p style="top:506.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">We aimed to systematically evaluate MSCs as a treat-</span></p>
<p style="top:519.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ment for mandibular ORN. Our search identified four</span></p>
<p style="top:531.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">animal studies and two case reports comprising three</span></p>
<p style="top:544.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">patients investigating the efficacy and safety of MSCs</span></p>
<p style="top:556.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">on mandibular ORN. MSC administration was safe and</span></p>
<p style="top:568.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">studies included in this review demonstrated a positive</span></p>
<p style="top:581.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">effect either as an increase in BV or BMD.</span></p>
<p style="top:593.8pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">There were differences regarding the impact of the MSC</span></p>
<p style="top:606.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">administration time as two animal studies had conflicting</span></p>
<p style="top:618.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">results; one study [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">15</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] identified an effect only if the MSCs</span></p>
<p style="top:631.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">were administered immediately after a bony defect was</span></p>
<p style="top:643.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">created, whereas another study [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] showed significant re-</span></p>
<p style="top:656.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">sults, when administering the MSCs four weeks postoper-</span></p>
<p style="top:668.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">atively. The difference might be due to the tissue source,</span></p>
<p style="top:681.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">being xenograft and allogenic respectively, but other dif-</span></p>
<p style="top:693.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ferences in study design might also influence the results.</span></p>
<p style="top:705.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The animal studies [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] observed soft tissue</span></p>
<p style="top:456.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">regeneration, increased epithelialization and soft tissue</span></p>
<p style="top:469.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">healing with the use of MSCs, although none of the studies</span></p>
<p style="top:481.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">quantitatively verified this effect. Janus et al. found a sig-</span></p>
<p style="top:494.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">nificant increase of fibrosis in all their treatment groups,</span></p>
<p style="top:506.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">compared to control and saline groups [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. As all groups,</span></p>
<p style="top:519.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the ones receiving MSCs and the one that did not, showed</span></p>
<p style="top:531.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">this effect, it is unlikely that MSCs, and not some other</span></p>
<p style="top:544.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">confounder, would have caused this outcome. One preclin-</span></p>
<p style="top:556.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ical study found a significant increase in the density of</span></p>
<p style="top:568.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">microvessels [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">16</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">], another found the same effect, which</span></p>
<p style="top:581.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">however was not quantified nor blinded [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">15</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. In the clinical</span></p>
<p style="top:593.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">study by Mendonca et al., MRI was used to identify neo-</span></p>
<p style="top:606.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">angiogenesis and a positive angiogenic effect was ob-</span></p>
<p style="top:618.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">served [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">37</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. There are also other previous studies, which</span></p>
<p style="top:631.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">have concluded that MSCs can enhance vasculogenesis</span></p>
<p style="top:643.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">after irradiation-induced tissue damage e.g. in bone [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">28</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">],</span></p>
<p style="top:656.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">skeletal muscle [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">32</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">], and colon [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">27</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Thus, MSCs may be</span></p>
<p style="top:668.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">beneficial in improving hypo-vascularity.</span></p>
<p style="top:681.0pt;left:317.5pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">To be identified as MSCs, the cells must meet certain</span></p>
<p style="top:693.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">criteria established by the International Society for Cell &amp;</span></p>
<p style="top:705.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Gene Therapy, ISCT [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">22</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. The criteria include morphology,</span></p>
<img style="position:absolute;transform:matrix(.3199204,0,-0,.31984217,72.98602,-421.82395)" src="data:image/png;base64,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">
<p style="top:407.6pt;left:306.1pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Fig. 2</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> SYRCLEs Risk of bias assessment tool. (?) = Unclear risk of bias,</span></p>
<p style="top:417.6pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(+) = Low risk of bias, (</span><span style="font-family:WtntwgQhctvpAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2212;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">) = High risk of bias</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1214</span></p>
<p style="top:33.5pt;left:400.1pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:58.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">growth kinetics, surface marker expression, plastic adherence,</span></p>
<p style="top:70.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and multipotential differentiation capacity; however, all these</span></p>
<p style="top:83.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">characteristics are defined by the</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">golden standard</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> i.e. BM-</span></p>
<p style="top:95.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">derived MSCs. Therefore, new statements have been made</span></p>
<p style="top:108.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">concerning the adipose tissue derived stromal cells and the</span></p>
<p style="top:120.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ability of MSCs to influence the immune system [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">39</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 40</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:133.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Even though the gross phenotypic appearance, such as marker</span></p>
<p style="top:145.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">expression and differentiation potential would be similar,</span></p>
<p style="top:158.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs from different tissues and species are not identical</span></p>
<p style="top:170.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">[</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">41</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. For example, it has been reported that bone marrow</span></p>
<p style="top:182.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and adipose tissue derived MSCs differ in gene expression,</span></p>
<p style="top:195.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">angiogenic potential, and secretion of various factors [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">42</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">].</span></p>
<p style="top:207.8pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">As the studies included in our systematic review utilized</span></p>
<p style="top:220.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs from various species and tissues, direct comparisons</span></p>
<p style="top:232.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">are very challenging. Either autologous or allogeneic cells</span></p>
<p style="top:245.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">as well as xenografts were used in the preclinical animal</span></p>
<p style="top:257.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">studies and the cells were originally derived from various</span></p>
<p style="top:270.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tissues, including bone marrow, tonsils or adipose tissue</span></p>
<p style="top:282.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">(Table</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">) [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">17</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. In the two human case studies, the cells</span></p>
<p style="top:294.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">were autologous but isolated from either bone marrow or</span></p>
<p style="top:307.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">dental pulp [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">36</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">,</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 37</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]. Furthermore, the isolation methods</span></p>
<p style="top:319.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and possible culture expansions varied between different</span></p>
<p style="top:332.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">studies, both of which are known to affect the biological</span></p>
<p style="top:344.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">characteristics of MSCs.</span></p>
<p style="top:357.2pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">In none of the preclinical or clinical case studies, were the</span></p>
<p style="top:369.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cells fully identified according to the above-defined MSC</span></p>
<p style="top:382.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">criteria. Janus et al. described testing the tri-lineage differen-</span></p>
<p style="top:394.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">tiation potential [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">14</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">] and Xu et al. performed Stro-1 and</span></p>
<p style="top:407.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">CD146 surface marker expression profiling but no data is</span></p>
<p style="top:419.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">shown. In one of the clinical cases, Mendonca et al. reported</span></p>
<p style="top:431.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">a partial MSC surface marker expression profile with 36% of</span></p>
<p style="top:444.4pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cells positive for CD90 and 14% for CD105, but 67% of cells</span></p>
<p style="top:456.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">were positive also for the hematopoietic marker CD45, indi-</span></p>
<p style="top:469.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cating that only a minority of cells in their study fulfilled the</span></p>
<p style="top:481.7pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">surface marker criteria for MSCs. Also, in the one clinical case</span></p>
<p style="top:494.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">by Manimaran et al., the cells injected were a very heteroge-</span></p>
<p style="top:506.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">nous cell population from uncultured bone marrow containing</span></p>
<p style="top:519.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">only a minor fraction of MSCs. [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">43</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">]</span></p>
<p style="top:531.6pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">In addition, despite of current attempts to unify the MSC</span></p>
<p style="top:544.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">nomenclature [</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff">44</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">], there is still discrepancy and confusion in</span></p>
<p style="top:556.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the current literature. Tissue-derived stromal cells can partially</span></p>
<p style="top:568.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">possess the same properties as MSCs and thus are sometimes</span></p>
<p style="top:581.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">incorrectly stated as</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. This raises further difficulty</span></p>
<p style="top:593.8pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">in comparing study outcomes and represents another source of</span></p>
<p style="top:606.3pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">confusion in cell therapy development.</span></p>
<p style="top:618.7pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">In addition to the risk of bias identified using the SYRCLEs</span></p>
<p style="top:631.2pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">risk of bias tool, there is a considerable risk of bias in the</span></p>
<p style="top:643.6pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">preclinical studies. A lot of methodology regarding selection</span></p>
<p style="top:656.1pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and housing of the animals, and blinding/randomization of the</span></p>
<p style="top:668.5pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">trials is either unreported or executed in a way resulting in</span></p>
<p style="top:681.0pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">increased risk of bias in the experiments.</span></p>
<p style="top:693.4pt;left:62.4pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The human case studies provide important initial clin-</span></p>
<p style="top:705.9pt;left:51.0pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ical data, although the very limited number of patients,</span></p>
<p style="top:58.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the lack of control groups, lack of well-characterized</span></p>
<p style="top:70.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cells, as well as potential bias and blinding precludes</span></p>
<p style="top:83.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the possibility of detailed, quantitative analysis. The lon-</span></p>
<p style="top:95.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">gest follow-up period was two years, which may not</span></p>
<p style="top:108.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">expose potential long-term side effects. However, these</span></p>
<p style="top:120.6pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">studies can be used as a model for potential upcoming</span></p>
<p style="top:133.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">human clinical trials.</span></p>
<p style="top:145.5pt;left:317.5pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">In conclusion, current preclinical literature suggests that</span></p>
<p style="top:158.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MSCs are safe with promising positive effects on osseous</span></p>
<p style="top:170.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">and soft tissue regeneration in ORN of the mandible. Our</span></p>
<p style="top:182.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">systematic review furthermore highlights the need for</span></p>
<p style="top:195.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">performing more controlled studies with well-characterized</span></p>
<p style="top:207.8pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cells to verify their efficacy.</span></p>
<p style="top:231.9pt;left:306.1pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Acknowledgements</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> Thank you to librarian Jette Meelby at the health</span></p>
<p style="top:241.8pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">scientific library at Nordsj&#xe6;llands Hospital Hiller&#xf8;d, for help with prep-</span></p>
<p style="top:251.8pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">aration and development of the search string.</span></p>
<p style="top:274.3pt;left:306.1pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Author Contributions</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> AG, CDL, CG and CvB conceived the study de-</span></p>
<p style="top:284.2pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">sign. AG, CL and LF were responsible for search preparation, literature</span></p>
<p style="top:294.2pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">search, article screening and selection. The initial draft of the manuscript</span></p>
<p style="top:304.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">was written by AG and CDL, and all authors critically revised the work.</span></p>
<p style="top:314.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">The final manuscript was read and approved by all authors.</span></p>
<p style="top:337.5pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Compliance with Ethical Standards</span></p>
<p style="top:361.9pt;left:306.1pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Conflict of Interest</span></p>
<p style="top:361.9pt;left:375.9pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">The authors declare no conflicts of interest.</span></p>
<p style="top:393.0pt;left:306.1pt;line-height:12.0pt"><span style="font-family:GnfgftRwwvyhAdvTTaf7f9f4,serif;font-size:12.0pt;color:#131313">Appendix</span></p>
<p style="top:418.7pt;left:306.1pt;line-height:11.0pt"><span style="font-family:JfvybwKdfhkdAdvTTa351d85,serif;font-size:11.0pt;color:#131313">Advanced search strategy</span></p>
<p style="top:444.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The final search was conducted on the 25th of March 2020.</span></p>
<p style="top:456.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The complete search strings can be found below. The</span></p>
<p style="top:469.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">MEDLINE search revealed 89 results, including MeSH terms.</span></p>
<p style="top:481.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">The EMBASE search revealed 128 studies including all paper</span></p>
<p style="top:494.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">types. These results were imported into</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> Covidence.org</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> 2020</span></p>
<p style="top:506.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">review software for screening. The screening process</span></p>
<p style="top:519.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">flowchart can be seen in Fig.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> 1</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">.</span></p>
<p style="top:531.6pt;left:317.5pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Cochrane Library was searched with fewer central key-</span></p>
<p style="top:544.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">words in order to identify reviews of interest. The keywords</span></p>
<p style="top:556.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">for condition were:</span></p>
<p style="top:568.9pt;left:317.5pt;line-height:10.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">osteoradionecrosis</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ORN</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">Osteoradionecrosis</span></p>
<p style="top:581.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">of the jaw</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ORNJ</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">ONJ</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">.</span></p>
<p style="top:593.8pt;left:317.5pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">This search revealed five Cochrane reviews. None of these</span></p>
<p style="top:606.3pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">reviews investigated the use of mesenchymal stem/stromal</span></p>
<p style="top:618.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">cells as a possible treatment for osteoradionecrosis, and thus</span></p>
<p style="top:631.2pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">the included studies of the reviews were not included in our</span></p>
<p style="top:643.7pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">analysis.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#0000ff"> ClinicalTrials.gov</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> was searched for all trials</span></p>
<p style="top:656.1pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">including the condition</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">osteoradionecrosis</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:10.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">. 14 results were</span></p>
<p style="top:668.5pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">found. Only one trial seemed to fit our inclusion criteria, and</span></p>
<p style="top:681.0pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">none of the exclusion criteria. However, in that study no</span></p>
<p style="top:693.4pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">results have been published, and the author did not respond</span></p>
<p style="top:705.9pt;left:306.1pt;line-height:10.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:10.0pt;color:#131313">to our inquiry.</span></p>
<p style="top:33.5pt;left:528.3pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1215</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:57.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Table 3</span></p>
<p style="top:57.1pt;left:86.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">MEDLINE Search</span></p>
<p style="top:75.9pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Osteoradionecrosis</span></p>
<p style="top:75.9pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">osteoradionecrosis</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">osteoradionecrosis</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:85.4pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">ONJ</span></p>
<p style="top:85.4pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Open Neuroendocrinol J</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[Journal] OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Open Nanomed J</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[Journal] OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">onj</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:94.8pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Mesenchymal stem cells</span></p>
<p style="top:94.8pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:104.3pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:113.8pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Mesenchymal stem cell</span></p>
<p style="top:113.8pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:123.2pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR</span></p>
<p style="top:132.7pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:142.2pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:151.6pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Mesenchymal stromal cells</span></p>
<p style="top:151.6pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:161.1pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR</span></p>
<p style="top:170.6pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:180.0pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stromal cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:189.5pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Mesenchymal stromal cell</span></p>
<p style="top:189.5pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:199.0pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR</span></p>
<p style="top:208.4pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:217.9pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stromal cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:227.4pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Stem cell</span></p>
<p style="top:227.4pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:236.8pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:246.3pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Stem cells</span></p>
<p style="top:246.3pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:255.8pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields]</span></p>
<p style="top:265.2pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Mesenchymal stem cell transplantation</span></p>
<p style="top:265.2pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cell transplantation</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span></p>
<p style="top:274.7pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">transplantation</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:284.1pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cell transplantation</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:293.6pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Stem cell transplantation</span></p>
<p style="top:293.6pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cell transplantation</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span></p>
<p style="top:303.1pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">transplantation</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cell transplantation</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:312.5pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Bone marrow</span></p>
<p style="top:312.5pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone</span></p>
<p style="top:322.0pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:331.5pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Bone marrow mesenchymal stem cells</span></p>
<p style="top:331.5pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:340.9pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:350.4pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:359.9pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone marrow mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:369.3pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Stem Cell, Mesenchymal</span></p>
<p style="top:369.3pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:378.8pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:388.3pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields])</span></p>
<p style="top:397.7pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Stem Cells, Mesenchymal</span></p>
<p style="top:397.7pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:407.2pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:416.7pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem cells,</span></p>
<p style="top:426.1pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:435.6pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Bone Marrow Stromal Cells</span></p>
<p style="top:435.6pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:445.0pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:454.5pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:463.9pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone marrow stromal cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:473.4pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Bone Marrow Stromal Cell</span></p>
<p style="top:473.4pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:482.9pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:492.4pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:501.8pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone marrow stromal cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:511.3pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Bone Marrow Stromal Cells, Multipotent</span></p>
<p style="top:511.3pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:520.8pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:530.2pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span></p>
<p style="top:539.7pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">multipotent</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields])</span></p>
<p style="top:549.2pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Multipotent Bone Marrow Stromal Cells</span></p>
<p style="top:549.2pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:558.6pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR</span></p>
<p style="top:568.1pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">multipotent</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">bone</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span></p>
<p style="top:577.6pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">multipotent bone marrow stromal</span></p>
<p style="top:587.0pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:596.5pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Adipose-Derived Mesenchymal Stem Cells</span></p>
<p style="top:596.5pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:606.0pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:615.4pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:624.8pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">adipose derived mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:634.3pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Adipose Derived Mesenchymal Stem Cells</span></p>
<p style="top:634.3pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:643.8pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:653.2pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:662.7pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">adipose derived mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]</span></p>
<p style="top:672.2pt;left:51.0pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Mesenchymal Stem Cells, Adipose-Derived</span></p>
<p style="top:672.2pt;left:245.4pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All</span></p>
<p style="top:681.6pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] OR</span></p>
<p style="top:691.1pt;left:253.9pt;line-height:8.0pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span></p>
<p style="top:700.6pt;left:253.9pt;line-height:8.0pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.0pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.0pt;color:#131313">[All Fields])</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1216</span></p>
<p style="top:33.5pt;left:400.1pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:54.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:RtdftmPnpnfcAdvTTb8864cc,serif;font-size:8.5pt;color:#131313">Table 3</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> (continued)</span></p>
<p style="top:70.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal Stem Cells, Adipose Derived</span></p>
<p style="top:70.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:80.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:90.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:100.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields])</span></p>
<p style="top:109.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Adipose-Derived Mesenchymal Stromal Cells</span></p>
<p style="top:109.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:119.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:129.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:139.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose derived mesenchymal stromal</span></p>
<p style="top:149.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:159.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Adipose Derived Mesenchymal Stromal Cells</span></p>
<p style="top:159.7pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:169.7pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:179.6pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:189.6pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose derived mesenchymal stromal</span></p>
<p style="top:199.6pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:209.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Adipose Tissue-Derived Mesenchymal Stem</span></p>
<p style="top:219.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Cells</span></p>
<p style="top:209.6pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:219.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:229.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tissue</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:239.4pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span></p>
<p style="top:249.4pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tissue derived mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:259.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Adipose Tissue Derived Mesenchymal Stem</span></p>
<p style="top:269.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Cells</span></p>
<p style="top:259.3pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:269.3pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:279.3pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tissue</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:289.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span></p>
<p style="top:299.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tissue derived mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:309.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Adipose Tissue-Derived Mesenchymal</span></p>
<p style="top:319.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Stromal Cells</span></p>
<p style="top:309.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:319.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:329.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tissue</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:339.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:349.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose tissue derived mesenchymal stromal cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:359.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Adipose Tissue Derived Mesenchymal</span></p>
<p style="top:368.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Stromal Cells</span></p>
<p style="top:359.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:368.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:378.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tissue</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">derived</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:388.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:398.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">adipose tissue derived mesenchymal stromal cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:408.8pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Stromal Cell, Mesenchymal</span></p>
<p style="top:408.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:418.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:428.7pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:438.7pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal cell, mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:448.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Stromal Cells, Mesenchymal</span></p>
<p style="top:448.6pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:458.6pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:468.6pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields])</span></p>
<p style="top:478.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Multipotent Mesenchymal Stromal Cells</span></p>
<p style="top:478.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:488.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:498.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">multipotent</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:508.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">multipotent mesenchymal stromal cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:518.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal Stromal Cells, Multipotent</span></p>
<p style="top:518.4pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:528.4pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:538.3pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span></p>
<p style="top:548.3pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">multipotent</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields])</span></p>
<p style="top:558.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal Progenitor Cell</span></p>
<p style="top:558.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:568.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:578.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">progenitor</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:588.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal progenitor cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:598.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal Progenitor Cells</span></p>
<p style="top:598.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:608.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:618.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">progenitor</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span></p>
<p style="top:628.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal progenitor cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:637.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Progenitor Cell, Mesenchymal</span></p>
<p style="top:637.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:647.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:657.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">progenitor</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields])</span></p>
<p style="top:667.8pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Progenitor Cells, Mesenchymal</span></p>
<p style="top:667.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:677.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:687.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">progenitor</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields])</span></p>
<p style="top:33.5pt;left:528.3pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1217</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:57.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:RtdftmPnpnfcAdvTTb8864cc,serif;font-size:8.5pt;color:#131313">Table 3</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> (continued)</span></p>
<p style="top:72.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Wharton Jelly Cells</span></p>
<p style="top:72.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:82.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:92.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">jelly</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">wharton jelly</span></p>
<p style="top:102.5pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:112.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s Jelly Cells</span></p>
<p style="top:112.4pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:122.4pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:132.4pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">jelly</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s</span></p>
<p style="top:142.3pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">jelly cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:152.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s Jelly Cell</span></p>
<p style="top:152.3pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:162.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:172.2pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">jelly</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s</span></p>
<p style="top:182.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">jelly cell</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:192.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Whartons Jelly Cells</span></p>
<p style="top:192.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:202.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR</span></p>
<p style="top:212.1pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">whartons</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">jelly</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">whartons</span></p>
<p style="top:222.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">jelly cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:232.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Bone Marrow Stromal Stem Cells</span></p>
<p style="top:232.0pt;left:245.4pt;line-height:8.5pt"><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[MeSH Terms] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:241.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] OR (</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">bone</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All</span></p>
<p style="top:251.9pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">marrow</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields] AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:261.8pt;left:245.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">AND</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]) OR</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x201c;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">bone marrow stromal stem cells</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x201d;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">[All Fields]</span></p>
<p style="top:343.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Table 4</span></p>
<p style="top:343.5pt;left:86.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Embase Search</span></p>
<p style="top:362.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1. ORN.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword,</span></p>
<p style="top:372.3pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">floating subheading word, candidate term word]</span></p>
<p style="top:385.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">2. ORNJ.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword,</span></p>
<p style="top:395.0pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">floating subheading word, candidate term word]</span></p>
<p style="top:407.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">3. ONJ.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword,</span></p>
<p style="top:417.6pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">floating subheading word, candidate term word]</span></p>
<p style="top:430.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">4. Mesenchymal stem cells.mp. or exp. mesenchymal stem cell/</span></p>
<p style="top:443.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">5. Mesenchymal stem cell.mp. or exp. mesenchymal stem cell/ or exp. stem cell/ or exp. mesenchyme cell/</span></p>
<p style="top:455.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">6. Mesenchymal stromal cells.mp. or exp. mesenchymal stroma cell/</span></p>
<p style="top:468.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">7. Mesenchymal stromal cell.mp. or exp. mesenchymal stroma cell/</span></p>
<p style="top:481.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">8. MSC.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword,</span></p>
<p style="top:491.1pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">floating subheading word, candidate term word]</span></p>
<p style="top:503.8pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">9. MSCs.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword,</span></p>
<p style="top:513.7pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">floating subheading word, candidate term word]</span></p>
<p style="top:526.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">10. Stem cell.mp. or exp. stem cell/</span></p>
<p style="top:539.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">11. Stem cells.mp. or exp. stem cell/</span></p>
<p style="top:551.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">12. Mesenchymal stem cell transplantation.mp. or exp. bone marrow transplantation/ or exp. mesenchymal stem cell transplantation/</span></p>
<p style="top:564.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">13. Stem cell transplantation.mp. or exp. bone marrow transplantation/ or exp. stem cell transplantation/</span></p>
<p style="top:577.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">14. Bone marrow aspirate concentrate.mp.</span></p>
<p style="top:590.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">15. BMAC.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword,</span></p>
<p style="top:599.9pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">floating subheading word, candidate term word]</span></p>
<p style="top:612.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">16. Bone marrow mesenchymal stem cell.mp. or exp. bone marrow derived mesenchymal stem cell/</span></p>
<p style="top:625.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">17. Bone marrow mesenchymal stem cells.mp. or exp. bone marrow derived mesenchymal stem cell/</span></p>
<p style="top:638.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">18. exp. mesenchymal stroma cell/ or exp. bone marrow cell/ or Bone marrow mesenchymal stromal cell.mp. or exp. mesenchymal stem cell/</span></p>
<p style="top:650.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">19. exp. mesenchymal stroma cell/ or Bone marrow mesenchymal stromal cells.mp. or exp. mesenchymal stem cell/</span></p>
<p style="top:663.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">20. BMMSC.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name,</span></p>
<p style="top:673.4pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">keyword, floating subheading word, candidate term word]</span></p>
<p style="top:686.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">21. BMMSCs.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name,</span></p>
<p style="top:696.0pt;left:59.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">keyword, floating subheading word, candidate term word]</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1218</span></p>
<p style="top:33.5pt;left:400.1pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:526.2pt;left:51.0pt;line-height:12.0pt"><span style="font-family:GnfgftRwwvyhAdvTTaf7f9f4,serif;font-size:12.0pt;color:#131313">References</span></p>
<p style="top:551.4pt;left:55.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1.</span></p>
<p style="top:551.4pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Chronopoulos, A., Zarra, T., Ehrenfeld, M., &amp; Otto, S. (2018,</span></p>
<p style="top:561.4pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">February 1). Osteoradionecrosis of the jaws: Definition, epidemiol-</span></p>
<p style="top:571.4pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">ogy, staging and clinical and radiological findings, A concise re-</span></p>
<p style="top:581.4pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">view.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> International Dental Journal. Wiley-Blackwell Publishing</span></p>
<p style="top:591.4pt;left:70.5pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Ltd., 68</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">, 22</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">30.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1111/idj.12318</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:602.4pt;left:55.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">2.</span></p>
<p style="top:602.4pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">St&#xf8;re, G., &amp; Boysen, M. (2000). Mandibular osteoradionecrosis:</span></p>
<p style="top:612.4pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Clinical behaviour and diagnostic aspects.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Clinical</span></p>
<p style="top:622.3pt;left:70.2pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Otolaryngology and Allied Sciences, 25</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(5), 378</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">384.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.</span></p>
<p style="top:632.4pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">org/10.1046/j.1365-2273.2000.00367.x</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:643.3pt;left:55.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">3.</span></p>
<p style="top:643.3pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Danielsson, D., Gahm, C., Haghdoost, S., Munck-Wikland, E., &amp;</span></p>
<p style="top:653.4pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Halle, M. (2020). Osteoradionecrosis, an increasing indication for</span></p>
<p style="top:663.3pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">microvascular head and neck reconstruction.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> International Journal</span></p>
<p style="top:673.3pt;left:70.2pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">of Oral and Maxillofacial Surgery, 49</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(1), 1</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">6.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.</span></p>
<p style="top:683.3pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">1016/j.ijom.2019.06.009</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:694.3pt;left:55.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">4.</span></p>
<p style="top:694.3pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Aarup-Kristensen, S., Hansen, C. R., Forner, L., Brink, C., Eriksen,</span></p>
<p style="top:704.3pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">J. G., &amp; Johansen, J. (2019). Osteoradionecrosis of the mandible</span></p>
<p style="top:526.5pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">after radiotherapy for head and neck cancer: Risk factors and dose-</span></p>
<p style="top:536.5pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">volume correlations. Acta Oncologica,</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> 0</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(0), 1</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">5.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.</span></p>
<p style="top:546.5pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">1080/0284186x.2019.1643037</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">, 58.</span></p>
<p style="top:556.8pt;left:310.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">5.</span></p>
<p style="top:556.8pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Shaw, R. J., Butterworth, C. J., Silcocks, P., Tesfaye, B. T.,</span></p>
<p style="top:566.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Bickerstaff, M., Jackson, R., Kanatas, A., Nixon, P., McCaul, J.,</span></p>
<p style="top:576.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Praveen, P., Lowe, T., Blanco-Guzman, M., Forner, L., Brennan,</span></p>
<p style="top:586.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">P., Fardy, M., Parkin, R., Smerdon, G., Stephenson, R., Cope, T., &amp;</span></p>
<p style="top:596.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Glover, M. (2019). HOPON (hyperbaric oxygen for the prevention</span></p>
<p style="top:606.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">of Osteoradionecrosis): A randomized controlled trial of hyperbaric</span></p>
<p style="top:616.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">oxygen to prevent Osteoradionecrosis of the irradiated mandible</span></p>
<p style="top:626.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">after Dentoalveolar surgery.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> International Journal of Radiation</span></p>
<p style="top:636.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Oncology*Biology*Physics, 104</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(3), 530</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">539.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.</span></p>
<p style="top:646.7pt;left:325.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">1016/j.ijrobp.2019.02.044</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:656.9pt;left:310.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">6.</span></p>
<p style="top:656.9pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Marx, R. E. (1983). Osteoradionecrosis: A new concept of its path-</span></p>
<p style="top:666.9pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">ophysiology.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Journal of Oral and Maxillofacial Surgery, 41</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(5),</span></p>
<p style="top:676.9pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">283</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">288.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/0278-2391(83)90294-X</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:687.2pt;left:310.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">7.</span></p>
<p style="top:687.2pt;left:326.9pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Rivero, J. A., Shamji, O., &amp; Kolokythas, A. (2017).</span></p>
<p style="top:697.1pt;left:326.9pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Osteoradionecrosis: a review of pathophysiology, prevention and</span></p>
<p style="top:707.1pt;left:326.9pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">pharmacologic management using pentoxifylline,</span><span style="font-family:WjygpxJnxqpyAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x3b1;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">-tocopherol,</span></p>
<p style="top:57.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:RtdftmPnpnfcAdvTTb8864cc,serif;font-size:8.5pt;color:#131313">Table 4</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> (continued)</span></p>
<p style="top:72.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">22. Stem Cell, Mesenchymal.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device</span></p>
<p style="top:82.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">trade name, keyword, floating subheading word, candidate term word]</span></p>
<p style="top:92.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">23. Stem Cell, Mesenchymal.mp. or exp. mesenchymal stem cell/</span></p>
<p style="top:102.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">24. exp. stem cell transplantation/ or exp. mesenchymal stem cell/ or Stem Cells, Mesenchymal.mp.</span></p>
<p style="top:112.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">25. Bone Marrow Stromal Cells.mp. or exp. bone marrow stroma cell/</span></p>
<p style="top:122.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">26. Bone Marrow Stromal Cell.mp. or exp. bone marrow stroma cell/</span></p>
<p style="top:132.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">27. exp. mesenchymal stroma cell/ or Bone Marrow Stromal Cells, Multipotent.mp.</span></p>
<p style="top:142.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">28. Multipotent Bone Marrow Stromal Cells.mp. or exp. bone marrow stroma cell/</span></p>
<p style="top:152.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">29. exp. mesenchymal stem cell/ or Adipose-Derived Mesenchymal Stem Cells.mp. or exp. adipose derived stem cell/</span></p>
<p style="top:162.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">30. exp. stem cell/ or exp. adipose derived stem cell/ or exp. mesenchymal stem cell/ or Adipose Derived Mesenchymal Stem Cells.mp.</span></p>
<p style="top:172.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">31. exp. bone marrow derived mesenchymal stem cell/ or exp. adipose derived stem cell/ or exp. stem cell transplantation/ or Mesenchymal Stem Cells,</span></p>
<p style="top:182.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Adipose-Derived.mp. or exp. mesenchymal stem cell/</span></p>
<p style="top:192.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">32. exp. mesenchymal stem cell/ or Mesenchymal Stem Cells, Adipose Derived.mp. or exp. stem cell transplantation/ or exp. adipose derived stem cell/</span></p>
<p style="top:202.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">33. exp. mesenchymal stroma cell/ or Adipose-Derived Mesenchymal Stromal Cells.mp. or exp. adipose derived stem cell/</span></p>
<p style="top:212.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">34. exp. mesenchymal stroma cell/ or Adipose Derived Mesenchymal Stromal Cells.mp. or exp. adipose derived stem cell/</span></p>
<p style="top:222.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">35. exp. mesenchymal stem cell/ or Adipose Tissue-Derived Mesenchymal Stem Cells.mp.</span></p>
<p style="top:232.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">36. exp. mesenchymal stem cell/ or Adipose Tissue Derived Mesenchymal Stem Cells.mp.</span></p>
<p style="top:241.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">37. exp. mesenchymal stroma cell/ or Adipose Tissue-Derived Mesenchymal Stromal Cells.mp.</span></p>
<p style="top:251.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">38. exp. mesenchymal stroma cell/ or Adipose Tissue Derived Mesenchymal Stromal Cells.mp.</span></p>
<p style="top:261.8pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">39. ADMSC.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name,</span></p>
<p style="top:271.8pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">keyword, floating subheading word, candidate term word]</span></p>
<p style="top:281.8pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">40. ADMSCs.mp. [mp = title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name,</span></p>
<p style="top:291.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">keyword, floating subheading word, candidate term word]</span></p>
<p style="top:301.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">41. exp. mesenchymal stroma cell/ or exp. mesenchymal stem cell/ or Stromal Cell, Mesenchymal.mp.</span></p>
<p style="top:311.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">42. exp. mesenchymal stroma cell/ or exp. mesenchymal stem cell/ or Stromal Cells, Mesenchymal.mp.</span></p>
<p style="top:321.7pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">43. exp. mesenchymal stroma cell/ or exp. multipotent stem cell/ or Multipotent Mesenchymal Stromal Cells.mp.</span></p>
<p style="top:331.6pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">44. exp. mesenchymal stroma cell/ or exp. mesenchymal stem cell/ or Mesenchymal Stromal Cells, Multipotent.mp.</span></p>
<p style="top:341.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">45. Mesenchymal Progenitor Cell.mp. or mesenchymal stem cell/</span></p>
<p style="top:351.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">46. Mesenchymal Progenitor Cells.mp. or exp. mesenchymal stem cell/</span></p>
<p style="top:361.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">47. exp. mesenchymal stem cell/ or exp. stem cell/ or Progenitor Cell, Mesenchymal.mp.</span></p>
<p style="top:371.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">48. exp. mesenchymal stem cell/ or Progenitor Cells, Mesenchymal.mp. or exp. stem cell transplantation/</span></p>
<p style="top:381.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">49. Wharton Jelly Cells.mp. or exp. mesenchymal stroma cell/</span></p>
<p style="top:391.4pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">50. exp. mesenchymal stem cell/ or exp. mesenchymal stroma cell/ or exp. Wharton jelly/ or Wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s Jelly Cells.mp.</span></p>
<p style="top:401.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">51. exp. mesenchymal stem cell/ or exp. mesenchymal stroma cell/ or exp. Wharton jelly/ or Wharton</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s Jelly Cell.mp.</span></p>
<p style="top:411.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">52. exp. mesenchymal stem cell/ or exp. mesenchymal stroma cell/ or exp. Wharton jelly/ or Whartons Jelly Cells.mp.</span></p>
<p style="top:421.3pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">53. exp. bone marrow stroma cell/ or Bone Marrow Stromal Stem Cells.mp.</span></p>
<p style="top:431.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">54. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31</span></p>
<p style="top:441.2pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53</span></p>
<p style="top:451.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">55. Osteoradionecrosis.mp.</span></p>
<p style="top:461.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">56. 1 or 2 or 3 or 55</span></p>
<p style="top:471.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">57. 54 and 56</span></p>
<p style="top:33.5pt;left:528.3pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1219</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:57.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">and clodronate. In</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Oral Surgery, Oral Medicine, Oral Pathology</span></p>
<p style="top:67.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">and Oral Radiology</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">. Elsevier Inc.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.oooo.</span></p>
<p style="top:77.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">2017.08.004</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:87.1pt;left:55.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">8.</span></p>
<p style="top:87.1pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Jacobson, A. S., Buchbinder, D., Hu, K., &amp; Urken, M. L. (2010).</span></p>
<p style="top:97.1pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Paradigm shifts in the management of osteoradionecrosis of the</span></p>
<p style="top:107.1pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mandible.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Oral Oncology, 46</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(11), 795</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">801.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.</span></p>
<p style="top:117.0pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">1016/j.oraloncology.2010.08.007</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:127.1pt;left:55.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">9.</span></p>
<p style="top:127.1pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Pereira, I. F., Firmino, R. T., Meira, H. C., Egito, V., Do, B. C.,</span></p>
<p style="top:137.1pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Vladimir-Reimar-Augusto-De Souza, N., &amp; Santos, V. R. (2018).</span></p>
<p style="top:147.1pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Osteoradionecrosis prevalence and associated factors: A ten years</span></p>
<p style="top:157.1pt;left:70.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">retrospective study.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Medicina Oral Patologia Oral y Cirugia</span></p>
<p style="top:167.0pt;left:70.2pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Bucal, 23</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(6), e633</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">e638.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.4317/medoral.22310</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:177.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">10.</span></p>
<p style="top:177.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Moon, D. H., Moon, S. H., Wang, K., Weissler, M. C., Hackman,</span></p>
<p style="top:187.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">T. G., Zanation, A. M., Thorp, B. D., Patel, S. N., Zevallos, J. P.,</span></p>
<p style="top:197.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Marks, L. B., &amp; Chera, B. S. (2017). Incidence of, and risk factors</span></p>
<p style="top:207.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">for, mandibular osteoradionecrosis in patients with oral cavity and</span></p>
<p style="top:217.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">oropharynx cancers.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Oral Oncology, 72</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">, 98</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">103.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.</span></p>
<p style="top:227.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">1016/j.oraloncology.2017.07.014</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:237.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">11.</span></p>
<p style="top:237.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Marx, R. E. (1983). A new concept in the treatment of</span></p>
<p style="top:247.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">osteoradionecrosis.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Journal of oral and maxillofacial surgery :</span></p>
<p style="top:257.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">official journal of the American Association of Oral and</span></p>
<p style="top:267.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Maxillofacial Surgeons, 41</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(6), 351</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">357.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/</span></p>
<p style="top:277.1pt;left:71.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">s0278-2391(83)80005-6</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:287.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">12.</span></p>
<p style="top:287.1pt;left:70.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Bennett, M. H., Feldmeier, J., Hampson, N. B., Smee, R., &amp;</span></p>
<p style="top:297.1pt;left:70.6pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Milross, C. (2016, April 28). Hyperbaric oxygen therapy for late</span></p>
<p style="top:307.1pt;left:70.6pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">radiation tissue injury. In</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cochrane Database of Systematic</span></p>
<p style="top:317.1pt;left:70.6pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Reviews.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> John Wiley and Sons Ltd.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1002/</span></p>
<p style="top:327.0pt;left:70.6pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">14651858.CD005005.pub4</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:337.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">13.</span></p>
<p style="top:337.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Dhanda, J., Pasquier, D., Newman, L., &amp; Shaw, R. (2016). Current</span></p>
<p style="top:347.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">concepts in Osteoradionecrosis after head and neck radiotherapy.</span></p>
<p style="top:357.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Clinical Oncology, 28</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(7), 459</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">466.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.clon.</span></p>
<p style="top:367.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">2016.03.002</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:377.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">14.</span></p>
<p style="top:377.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Janus, J. R., Jackson, R. S., Lees, K. A., Voss, S. G., Wilson, Z. C.,</span></p>
<p style="top:387.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Remmes, N. B., Keeney, M. G., Garcia, J. J., &amp; San Marina, S.</span></p>
<p style="top:397.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(2017). Human adipose-derived Mesenchymal stem cells for osse-</span></p>
<p style="top:407.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">ous rehabilitation of induced Osteoradionecrosis: A rodent model.</span></p>
<p style="top:417.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Otolaryngology - Head and Neck Surgery (United States), 156</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(4),</span></p>
<p style="top:427.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">616</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">621.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1177/0194599816688647</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:437.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">15.</span></p>
<p style="top:437.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Park, H. S., Lee, J., Kim, J.-W. W., Kim, H. S. Y. S. Y. S., Jung, S.</span></p>
<p style="top:447.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Y., Lee, S. M., et al. (2018). Preventive effects of tonsil-derived</span></p>
<p style="top:457.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells on osteoradionecrosis in a rat model.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Head</span></p>
<p style="top:467.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">and Neck, 40</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(3), 526</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">535.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1002/hed.25004</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:477.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">16.</span></p>
<p style="top:477.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Xu, J., Zheng, Z., Fang, D., Gao, R., Liu, Y., Fan, Z., et al. (2012).</span></p>
<p style="top:487.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal stromal cell-based treatment of jaw</span></p>
<p style="top:497.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">osteoradionecrosis in swine.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cell Transplantation, 21</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(8), 1679</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span></p>
<p style="top:507.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1686.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.3727/096368911X637434</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:517.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">17.</span></p>
<p style="top:517.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Jin, I. G., Kim, J. H., Wu, H. G., Kim, S. K., Park, Y., Hwang, S. J.,</span></p>
<p style="top:527.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">et al. (2015). Effect of bone marrow-derived stem cells and bone</span></p>
<p style="top:537.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">morphogenetic protein-2 on treatment of osteoradionecrosis in a rat</span></p>
<p style="top:547.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">model.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Journal of Cranio-Maxillofacial Surgery, 43</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(8), 1478</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span></p>
<p style="top:557.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1486.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.jcms.2015.06.035</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:567.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">18.</span></p>
<p style="top:567.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., &amp; Frolova,</span></p>
<p style="top:577.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">G. P. (1968). Heterotopic of bone marrow. Analysis of precursor</span></p>
<p style="top:587.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells for osteogenic and hematopoietic tissues. In</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Transplantation :</span></p>
<p style="top:597.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Official journal of the Transplantation Society</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">. Baltimore, Md.:</span></p>
<p style="top:607.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Lippott Williams and Wilkins.</span></p>
<p style="top:617.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">19.</span></p>
<p style="top:617.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Singer, N. G., &amp; Caplan, A. I. (2011). Mesenchymal stem cells:</span></p>
<p style="top:627.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mechanisms of inflammation.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Annual Review of Pathology:</span></p>
<p style="top:637.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Mechanisms of Disease, 6</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(1), 457</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">478.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1146/</span></p>
<p style="top:647.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">annurev-pathol-011110-130230</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:657.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">20.</span></p>
<p style="top:657.1pt;left:71.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Caplan, A. (1991). Mesenchymal stem cells.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Journal of</span></p>
<p style="top:667.1pt;left:71.7pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Orthopaedic Research : Official Publication of the Orthopaedic</span></p>
<p style="top:677.1pt;left:71.7pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Research Society, 9</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(5), 641</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">650.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1002/jor.</span></p>
<p style="top:687.1pt;left:71.7pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">1100090504</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:697.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">21.</span></p>
<p style="top:697.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">da Silva Meirelles, L., Fontes, A. M., Covas, D. T., &amp; Caplan, A. I.</span></p>
<p style="top:707.1pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(2009). Mechanisms involved in the therapeutic properties of</span></p>
<p style="top:57.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stem cells.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cytokine &amp; Growth Factor Reviews,</span></p>
<p style="top:67.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">20</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(5</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">6), 419</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">427.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.cytogfr.2009.10.002</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:77.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">22.</span></p>
<p style="top:77.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I.,</span></p>
<p style="top:87.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Marini, F. . C., Krause, D. S. S.,</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x2026;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> Horwitz, E. M. M. (2006).</span></p>
<p style="top:97.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Minimal criteria for defining multipotent mesenchymal stromal</span></p>
<p style="top:107.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells. The International Society for Cellular Therapy position state-</span></p>
<p style="top:117.0pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">ment. Cytotherapy, 8(4), 315</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">317.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1080/</span></p>
<p style="top:127.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">14653240600855905</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:137.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">23.</span></p>
<p style="top:137.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Caplan, A. I. (2017). Mesenchymal stem cells: Time to change the</span></p>
<p style="top:147.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">name!</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Stem Cells Translational Medicine, 6</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(6), 1445</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1451.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://</span></p>
<p style="top:157.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">doi.org/10.1002/sctm.17-0051</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:167.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">24.</span></p>
<p style="top:167.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Squillaro, T., Peluso, G., &amp; Galderisi, U. (2016). Clinical trials with</span></p>
<p style="top:177.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal stem cells: An update.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cell Transplantation, 25</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(5),</span></p>
<p style="top:187.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">829</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">848.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.3727/096368915X689622</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:197.2pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">25.</span></p>
<p style="top:197.2pt;left:326.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Ankrum, J. A., Ong, J. F., &amp; Karp, J. M. (2014, March).</span></p>
<p style="top:207.1pt;left:326.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal stem cells: Immune evasive, not immune privileged.</span></p>
<p style="top:217.1pt;left:326.4pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Nature Biotechnology. NIH Public Access., 32</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">, 252</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">260.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://</span></p>
<p style="top:227.1pt;left:326.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">doi.org/10.1038/nbt.2816</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:237.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">26.</span></p>
<p style="top:237.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Prockop, D. J. (2017). The exciting prospects of new therapies with</span></p>
<p style="top:247.2pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mesenchymal stromal cells.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cytotherapy. NIH Public Access., 19</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">,</span></p>
<p style="top:257.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">8.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.jcyt.2016.09.008</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:267.2pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">27.</span></p>
<p style="top:267.2pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Van de Putte, D., Demarquay, C., Van Daele, E., Moussa, L.,</span></p>
<p style="top:277.2pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Vanhove, C., Benderitter, M., et al. (2017). Adipose-derived</span></p>
<p style="top:287.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal stromal cells improve the healing of colonic anasto-</span></p>
<p style="top:297.2pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">moses following high dose of irradiation through anti-inflammatory</span></p>
<p style="top:307.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">and Angiogenic processes.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cell Transplantation, 26</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(12), 1919</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span></p>
<p style="top:317.1pt;left:325.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1930.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1177/0963689717721515</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:327.2pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">28.</span></p>
<p style="top:327.2pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">S.S., D., K.K., G., A., D., N.S., N., N.P., G., P.A., F</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> &#x2026;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> Buchman, S.</span></p>
<p style="top:337.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">R. (2015). Stem cells rejuvenate radiation-impaired vasculogenesis</span></p>
<p style="top:347.2pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">in murine distraction osteogenesis. Plastic and Reconstructive</span></p>
<p style="top:357.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Surgery, 135(3), 799</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">806.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1097/PRS.</span></p>
<p style="top:367.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">0000000000001024</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:377.2pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">29.</span></p>
<p style="top:377.2pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Gr&#xf8;nh&#xf8;j, C., Jensen, D. H., Vester-Glowinski, P., Jensen, S. B.,</span></p>
<p style="top:387.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Bardow, A., Oliveri, R. S., Fog, L. M., Specht, L., Thomsen, C.,</span></p>
<p style="top:397.2pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Darkner, S., Jensen, M., M&#xfc;ller, V., Kiss, K., Agander, T.,</span></p>
<p style="top:407.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Andersen, E., Fischer-Nielsen, A., &amp; von Buchwald, C. (2018).</span></p>
<p style="top:417.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Safety and efficacy of Mesenchymal stem cells for radiation-</span></p>
<p style="top:427.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">induced Xerostomia: A randomized, placebo-controlled phase 1/2</span></p>
<p style="top:437.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">trial (MESRIX).</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> International Journal of Radiation Oncology</span></p>
<p style="top:447.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Biology Physics, 101</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(3), 581</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">592.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.</span></p>
<p style="top:457.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">ijrobp.2018.02.034</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:467.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">30.</span></p>
<p style="top:467.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Soria, B., Martin-Montalvo, A., Aguilera, Y., Mellado-Damas, N.,</span></p>
<p style="top:477.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">L&#xf3;pez-Beas, J., Herrera-Herrera, I., L&#xf3;pez, E., Barcia, J. A.,</span></p>
<p style="top:487.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Alvarez-Dolado, M., Hmadcha, A., &amp; Capilla-Gonz&#xe1;lez, V.</span></p>
<p style="top:497.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(2019). Human Mesenchymal stem cells prevent neurological com-</span></p>
<p style="top:507.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">plications of radiotherapy.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Frontiers in Cellular Neuroscience,</span></p>
<p style="top:517.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">13</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(May), 1</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">14.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.3389/fncel.2019.00204</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:527.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">31.</span></p>
<p style="top:527.1pt;left:326.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Zanoni, Cortesi, Zamagni, &amp; Tesei. (2019). The role of</span></p>
<p style="top:537.1pt;left:326.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal stem cells in radiation-induced lung fibrosis.</span></p>
<p style="top:547.1pt;left:326.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">International Journal of Molecular Sciences, 20(16), 3876.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://</span></p>
<p style="top:557.1pt;left:326.8pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">doi.org/10.3390/ijms20163876</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:567.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">32.</span></p>
<p style="top:567.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Linard, C., Brachet, M., L</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">homme, B., Strup-Perrot, C., Busson, E.,</span></p>
<p style="top:577.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Bonneau, M., Lataillade, J. J., Bey, E., &amp; Benderitter, M. (2018).</span></p>
<p style="top:587.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Long-term effectiveness of local BM-MSCs for skeletal muscle</span></p>
<p style="top:597.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">regeneration: A proof of concept obtained on a pig model of severe</span></p>
<p style="top:607.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">radiation burn.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Stem Cell Research &amp; Therapy, 9</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(1), 299.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://</span></p>
<p style="top:617.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">doi.org/10.1186/s13287-018-1051-6</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:627.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">33.</span></p>
<p style="top:627.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Heino, T. J., &amp; Hentunen, T. A. (2008). Differentiation of osteo-</span></p>
<p style="top:637.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">blasts and osteocytes from mesenchymal stem cells.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Current stem</span></p>
<p style="top:647.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">cell research &amp; therapy, 3</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(2), 131</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">145 Retrieved from</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> http://www.</span></p>
<p style="top:657.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">ncbi.nlm.nih.gov/pubmed/18473879</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:667.1pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">34.</span></p>
<p style="top:667.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Birmingham, E., Niebur, G., McHugh, P., Shaw, G., Barry, F., &amp;</span></p>
<p style="top:677.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">McNamara, L. (2016). Osteogenic differentiation of mesenchymal</span></p>
<p style="top:687.2pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stem cells is regulated by osteocyte and osteoblast cells in a simpli-</span></p>
<p style="top:697.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">fied bone niche.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> European Cells and Materials, 23</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(353), 13</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">27.</span></p>
<p style="top:707.1pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">https://doi.org/10.22203/ecm.v023a02</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1220</span></p>
<p style="top:33.5pt;left:400.1pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>


<p style="top:57.1pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">35.</span></p>
<p style="top:57.1pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Moher, D., Liberati, A., Tetzlaff, J., &amp; Altman, D. G. (2009).</span></p>
<p style="top:67.1pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Preferred reporting items for systematic reviews and meta-analyses:</span></p>
<p style="top:77.1pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">The PRISMA statement.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Journal of Clinical Epidemiology, 62</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(10),</span></p>
<p style="top:87.1pt;left:70.5pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1006</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1012.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.jclinepi.2009.06.005</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:97.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">36.</span></p>
<p style="top:97.0pt;left:71.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Manimaran, K., Sankaranarayanan, S., Chandramohan, M.,</span></p>
<p style="top:107.1pt;left:71.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Elangovan, S., Perumal, S. M., Ravi, V. R., et al. (2014).</span></p>
<p style="top:117.0pt;left:71.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Treatment of osteoradionecrosis of mandible with bone marrow</span></p>
<p style="top:127.0pt;left:71.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">concentrate and with dental pulp stem cells.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Annals of</span></p>
<p style="top:137.0pt;left:71.1pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Maxillofacial Surgery, 4</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(2), 189</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">192.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.4103/</span></p>
<p style="top:147.0pt;left:71.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">2231-0746.147130</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:157.0pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">37.</span></p>
<p style="top:157.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mendon&#xe7;a, J. J., Juiz-Lopez, P., Mendonca, J. J., Juiz-Lopez, P.,</span></p>
<p style="top:167.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mendon&#xe7;a, J. J., Juiz-Lopez, P., et al. (2010). Regenerative facial</span></p>
<p style="top:177.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">reconstruction of terminal stage osteoradionecrosis and other ad-</span></p>
<p style="top:187.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">vanced craniofacial diseases with adult cultured stem and progeni-</span></p>
<p style="top:197.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tor cells.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Plastic and Reconstructive Surgery, 126</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(5), 1699</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1709.</span></p>
<p style="top:207.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">https://doi.org/10.1097/PRS.0b013e3181f24164</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:216.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">38.</span></p>
<p style="top:216.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M.,</span></p>
<p style="top:227.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Ritskes-Hoitinga, M., &amp; Langendam, M. W. (2014). SYRCLE</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">s</span></p>
<p style="top:237.0pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">risk of bias tool for animal studies.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> BMC Medical Research</span></p>
<p style="top:246.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">Methodology, 14</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(1), 43.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1186/1471-2288-14-43</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:256.9pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">39.</span></p>
<p style="top:256.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Bourin, P., Bunnell, B. A., Casteilla, L., Dominici, M., Katz, A. J.,</span></p>
<p style="top:266.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">March, K. L., Redl, H., Rubin, J. P., Yoshimura, K., &amp; Gimble, J.</span></p>
<p style="top:276.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">M. (2013). Stromal cells from the adipose tissue-derived stromal</span></p>
<p style="top:286.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">vascular fraction and culture expanded adipose tissue-derived</span></p>
<p style="top:296.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">stromal/stem cells: A joint statement of the International</span></p>
<p style="top:306.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Federation for Adipose Therapeutics and Science (IFATS) and</span></p>
<p style="top:316.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">the international so.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cytotherapy, 15</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(6), 641</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">648.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/</span></p>
<p style="top:326.9pt;left:70.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">10.1016/j.jcyt.2013.02.006</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:336.8pt;left:51.0pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">40.</span></p>
<p style="top:336.8pt;left:70.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Galipeau, J., Krampera, M., Barrett, J., Dazzi, F., Deans, R. J.,</span></p>
<p style="top:346.9pt;left:70.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">DeBruijn, J., Dominici, M., Fibbe, W. E., Gee, A. P., Gimble, J.</span></p>
<p style="top:356.9pt;left:70.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">M., Hematti, P., Koh, M. B. C., LeBlanc, K., Martin, I., McNiece, I.</span></p>
<p style="top:57.1pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">K., Mendicino, M., Oh, S., Ortiz, L., Phinney, D. G., Planat, V.,</span></p>
<p style="top:67.1pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Shi, Y., Stroncek, D. F., Viswanathan, S., Weiss, D. J., &amp; Sensebe,</span></p>
<p style="top:77.1pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">L. (2015). International Society for Cellular Therapy perspective on</span></p>
<p style="top:87.1pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">immune functional assays for mesenchymal stromal cells as poten-</span></p>
<p style="top:97.0pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cy release criterion for advanced phase clinical trials.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cytotherapy,</span></p>
<p style="top:107.1pt;left:325.4pt;line-height:8.5pt"><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313">18</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(2), 151</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">159.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.jcyt.2015.11.008</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:118.0pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">41.</span></p>
<p style="top:118.0pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Uder, C., Br&#xfc;ckner, S., Winkler, S., Tautenhahn, H.-M., &amp; Christ,</span></p>
<p style="top:128.0pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">B. (2018). Mammalian MSC from selected species: Features and</span></p>
<p style="top:138.0pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">applications.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cytometry Part A, 93</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(1), 32</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">49.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.</span></p>
<p style="top:148.0pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff">1002/cyto.a.23239</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:159.0pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">42.</span></p>
<p style="top:159.0pt;left:326.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., &amp;</span></p>
<p style="top:169.0pt;left:326.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Michalek, J. (2012). Same or not the same? Comparison of adipose</span></p>
<p style="top:179.0pt;left:326.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tissue-derived versus bone marrow-derived Mesenchymal stem</span></p>
<p style="top:189.0pt;left:326.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">and stromal cells.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Stem Cells and Development, 21</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(14), 2724</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span></p>
<p style="top:199.0pt;left:326.3pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">2752.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1089/scd.2011.0722</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:210.0pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">43.</span></p>
<p style="top:210.0pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Alvarez-Viejo, M., Menendez-Menendez, Y., Blanco-Gelaz, M.</span></p>
<p style="top:219.9pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">A., Ferrero-Gutierrez, A., Fernandez-Rodriguez, M. A., Gala, J.,</span></p>
<p style="top:229.9pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&amp; Otero-Hernandez, J. (2013). Quantifying Mesenchymal stem</span></p>
<p style="top:240.0pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">cells in the mononuclear cell fraction of bone marrow samples</span></p>
<p style="top:249.9pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">obtained for cell therapy.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Transplantation Proceedings, 45</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(1),</span></p>
<p style="top:259.9pt;left:325.4pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">434</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">439.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.transproceed.2012.05.091</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:270.9pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">44.</span></p>
<p style="top:270.9pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Viswanathan, S., Shi, Y., Galipeau, J., Krampera, M., Leblanc, K.,</span></p>
<p style="top:280.9pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Martin, I., Nolta, J., Phinney, D. G., &amp; Sensebe, L. (2019).</span></p>
<p style="top:290.9pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Mesenchymal stem versus stromal cells: International Society for</span></p>
<p style="top:300.9pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">Cell &amp;amp; gene therapy (ISCT&#xae;) Mesenchymal stromal cell com-</span></p>
<p style="top:310.9pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">mittee position statement on nomenclature.</span><span style="font-family:HhvbfjBfmlrvAdvTT50a2f13,serif;font-size:8.5pt;color:#131313"> Cytotherapy, 21</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">(10),</span></p>
<p style="top:320.9pt;left:325.2pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1019</span><span style="font-family:FmcnqhSfhpfmAdvTT3713a23,serif;font-size:8.5pt;color:#131313">&#x2013;</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">1024.</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#0000ff"> https://doi.org/10.1016/j.jcyt.2019.08.002</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">.</span></p>
<p style="top:344.3pt;left:306.1pt;line-height:8.5pt"><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">Publisher</span><span style="font-family:WylnytMpsnqwAdvTT577c760,serif;font-size:8.5pt;color:#131313">&#x2019;</span><span style="font-family:CsdmpwVdwkdkAdvTT577c760,serif;font-size:8.5pt;color:#131313">s Note</span><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313"> Springer Nature remains neutral with regard to jurisdic-</span></p>
<p style="top:354.2pt;left:306.1pt;line-height:8.5pt"><span style="font-family:LycxqrJnxqtvAdvTT3713a23,serif;font-size:8.5pt;color:#131313">tional claims in published maps and institutional affiliations.</span></p>
<p style="top:33.5pt;left:528.3pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">1221</span></p>
<p style="top:33.5pt;left:51.0pt;line-height:8.5pt"><span style="font-family:TktgqnMyriadProUnicSemiC,serif;font-size:8.5pt">Stem Cell Rev and Rep  (2020) 16:1208&#x2013;1221</span></p>

</div>
